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In this thesis, two different potential fluorescent probes for metal ions and four 
potential anticancer drugs have been designed, synthesised, characterised and studied for 
their metal binding properties and biological applications. 
 
This report aims to design and synthesise amino acid-derived ligands as potential 
metal ion sensors in biological and aqueous systems. Metal ions play many pivotal roles in 
biological systems such as catalysing biochemical reactions and creating action potentials 
allowing for the movement of organisms. Dysfunction of such metals can contribute to the 
development of diseases such as Alzheimer’s disease (AD) and Wilson’s disease. As a result, 
the biological roles of metal ions are of great intrigue to many scientists in multiple fields. 
These researchers depend upon the development of more ideal fluorescent sensors for metal 
ions to conduct their investigations. Unfortunately, current fluorescent probes for metal ions 
have limitations such as poor selectivity to their analyte, weak fluorescence intensity, and are 
often unsuitable for biological application due to poor water solubility, and high cytotoxicity. 
Therefore, the development of new probes is important to enhance the knowledge of metal 
ions in biology and medicine.  
 
The fluorescent sensors synthesised in this thesis report that undergo cell viability 
assays with low effective concentration (EC) values are declared inappropriate for biological 
metal sensing. Their high cytotoxicity is therefore explored as potential anticancer agents 
when bound to lanthanides. Cancer constitutes to the top three of the total world’s deaths. 
Platinum-based anticancer drugs have been the focal point of many chemotherapies used to 
treat cancer-related illnesses, however, are limited with intrinsic resistance and have negative 
side-effects due to a lack of cell selectivity. Other metal-based therapies, such as lanthanides-
based therapies, have come of intrigue as potential substitutes for platinum-based drugs due 
to their unique properties. Despite the potential of lanthanide complexes as alternative 
anticancer therapies, this area of research has not received much attention. 
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Chapter 1 - Introduction 
 
1.1 Supramolecular Chemistry 
 
Jean-Marie Lehn, a joint 1987 Nobel Prize winner in chemistry with Donald J. Cram 
and Charles J. Pederson, for their ‘development and use of molecules with structure-specific 
interactions of high selectivity’, defined supramolecular chemistry as the ‘chemistry of 
molecular assemblies and intermolecular bonds’. More colloquially supramolecular 
chemistry is frequently described as ‘chemistry, beyond the molecule’.
1
 This field of 
chemistry is predominately concerned with the study of host-guest interactions between 
molecules. This is where a ‘host’ molecule encapsulates a ‘guest’ molecule or ion, forming a 
more complex ‘super’ molecule, hence the term ‘supramolecular chemistry’.
1-3
 These host-
guest interactions can occur synthetically, for example with some complexes of crown ethers. 
Conversely, many structures can spontaneously assemble into more distinctive architectures 
such as helicates and coordination cages. These naturally forming larger, more complex 
assemblies are more thermodynamically favourable than basic host-guest interactions. These 
complicated structures have been observed in biology notably in the double helix structure of 
deoxyribonucleic acid (DNA), protein folding and aggregation, as well as micelle and 
phospholipid bilayer formations.
4-6
 This process by which molecules spontaneously assemble 
into complex three-dimensional structures is referred to as ‘self-assembly’.
7,8
 In 
supramolecular chemistry, the assemblies of such molecules are frequently held together by 
weak intermolecular bond formations including hydrogen bonding, hydrophobic forces, π-π 
stacking and Van der Waals forces.
1,2,9
 In metallo-supramolecular chemistry, a branch of 
supramolecular chemistry, these molecules are held together by not just intermolecular forces 
but also, coordinate covalent bonds. Coordinate covalent bonds exist where a metal ion acts 
as a Lewis acid and a donor atom acts as a Lewis base, donating two electrons to its 
corresponding Lewis acid to form coordination bonds.
10 
 
 Due to its interdisciplinary nature, supramolecular chemistry is prevalently studied in 
multiple fields of science such as chemistry, physics, biology, biochemistry material and 
natural science. Within the last few decades, supramolecular chemistry has provided many 
developments and supramolecular assemblies have incorporated much interest to scientists in 
2 
many different fields for their magnetic, electrochemical, optical, medical and chemosensory 
properties.
4,11,12
    
 
1.1.1 Metallo-Supramolecular Chemistry 
 
 Metallo-supramolecular chemistry involves the host-guest interaction between an 
organic ligand and a metal ion. As previously mentioned, this is where an inorganic metal ion 
acts as a Lewis acid and donor atom(s) from the organic compound act as a Lewis base 
donating two electrons to the Lewis acid in a coordinate covalent bond.
10
 Therefore, the 
organic molecule is coined as the ‘host’ molecule and the metal ion as the ‘guest’ molecule. 
The result is a supramolecular assembly formed from ligand and metal with a variety of 
different stoichiometry and coordinate geometries depending on molecules involved, the 
states of the molecules, as well as other reaction conditions. These supramolecular assemblies 
may be simple in structure, however, can result in the formation of more complicated 
macromolecules such as coordination cages and metal helicates resulting in a variety of 
applications and enhancing the understanding of multiple fields.
13,14 
 
1.1.1.1 Hard-Soft Acid-base (HSAB) Theory 
 
Supramolecular molecules are carefully designed and synthesised for specific 
purposes. It is therefore essential to consider multiple different basic inorganic chemistry 
concepts including the hard-soft acid-base (HSAB) theory. The HSAB theory simply states 
that a hard Lewis acid prefers to coordinate with a hard Lewis base. Conversely a soft Lewis 
acid prefers a soft Lewis base. The terms ‘hard’ and soft’ refer to the polarisability of the 
metal ion and ligand. Hard acids are metals with a high charge density and are therefore 
weakly polarisable and so prefer to coordinate to weakly polarisable bases. Hard acids 
typically consist of a multivalent charge as this increases charge density. Monovalent metals 
are often hard acids if they exhibit a small atomic radius which also increases charge density. 
Soft metals however, are highly polarisable metals with a low charge density. They are 
typically monovalent and exhibit large atomic radii. Soft acids prefer to coordinate to soft 
bases as soft bases too are typically highly polarisable.
15-18
 Table 1.1 lists a range of some 




Table 1.1 Examples of some common hard, soft and intermediate Lewis acid and bases.
18,19
 





















































































The HSAB theory is generally a rule of thumb as there are many documented cases of 
hard acids coordinating to soft bases and vice versa. This is because other factors affect the 
bond strength between donor and acceptor atoms including atomic size, charge, 
electronegativity and orbital overlap.
18
 Generally, when a hard acid is coordinated to a hard 
base and soft acid to a soft base, metallic complexes have a tendency to exhibit greater 
stability. Therefore, HSAB theory is frequently considered by supramolecular chemists when 
designing ligands for their specific applications. 
 
1.1.1.2 Irving-William’s Series 
  
  The Irving-William’s series explains the binding stability of divalent d-block metals 
from manganese to zinc. In 1953 Harry Irving and Robert Williams investigated the stability 
of divalent d-block metals where they concluded that stability increase across the periodic 
table from manganese until copper where stability peaks. Irving and William’s then proposed 















From manganese to zinc, the atomic radii decreases resulting in an enhancement of 
stability explaining the increased stability for d-block metals from left to right of the periodic 
table. Crystal field stabilisation energy (CFSE) increases from manganese and peaks at nickel 
and so, therefore, it would be predicted that nickel would form the most stable complexes of 
the six different divalent d-block metals. However, as octahedral Cu
2+
 complexes exhibit 
Jahn-Teller distortion, the stability of octahedral Cu
2+




the results found by Irving and Williams.
18-20
   
 
1.2 Metals in Biology 
 
Metal biochemistry plays pivotal roles to the health and function of living organisms 
and ecosystems. Inorganic chemistry has enhanced a greater understanding and development 
of biochemical and medicinal practices. Metals in biological systems have been of great 
interest to scientists in multiple fields and methods that contribute to greater understandings 
of the roles metals play in biology are sought. Although metal ions are essential for regular 
function, imbalances, dysregulation and environmental changes (both micro and macro) can 
alter the function of such metals potentially leading to toxicity. Metals are found in every 
cell. It has been found that as many as a third of all proteins and half of all enzymes in the 
human proteome require metals for catalytic function and/or to maintain their structures.
21,22
. 
There are 22 essential elements for life, 10 of which are metals. This, however, includes 
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Figure 1.1 Periodic table indicating the biologically essential elements. Essential elements 
for most forms of life are shown in red with the exception of chromium (Cr), which is shown 
in yellow. Essential elements that are restricted for some forms of life are shown in amber. 






Calcium, sodium, potassium and magnesium are metals coined as macrominerals. 
They exhibit weak to intermediate binding affinities to biological ligands such as peptides 
and proteins, however, are highly mobile and perform a wide range of different biological 
functions such as behaving as charge carriers and are responsible for generating movement as 
well as sensation from external stimuli. An excess of such metals can result in cells to 
become hypertonic due to osmotic pressure and can develop into diseases such as 
hypernatremia and hyperkalaemia which results in cardiovascular diseases and potential 
death.
23,25,26
 Elements such as manganese, iron, copper, zinc and molybdenum are scarcely 
abundant and yet are essential elements. They typically have strong binding affinities for 
biological ligands; however, have lower mobility than the macrominerals. They perform 
many vital biological roles such as acting as Lewis acids and redox catalysts in enzymes and 
essential vitamins. Dysregulation of metals such as iron, copper and zinc has been closely 
linked to neurological disorders such as AD.
23,26,27
 There are other metals which play minor, 
non-essential roles in biological functions. Most of these metals are innocuous in trace 
amounts whilst some can be excreted naturally. Heavy metal poisoning often results from 
generally non-prevalent minerals such as gold and silver accumulating in vital organs such as 
the liver with no method of renal excretion, potentially resulting in organ failure.
28
 Other 
heavy metals such as mercury can cause severe neurodegeneration when coordinated to 
organic biomolecules allowing for diffusion across the blood-brain barier.
29
 Metals such as 
cadmium can mimic and competitively inhibit the functions of essential elements such as 
calcium due to having comparably similar atomic size and charge. This has been associated 
with such diseases as osteomalacia and osteoporosis.
30
 Metals such as aluminium do not 
account for a significant portion of biological elements, however, exist in a high abundance 
of the Earth’s crust. Minor alterations to pH or mismanagements of ecosystems can result in 




Aluminium is the most abundant metal element in the lithosphere accounting to 8.3% 
of the total mass in the Earth’s crust and is the ninth most abundant metal found in 
humans.
33,34
 Its cytotoxicity towards organisms is of intrigue to scientists in multiple 
disciplines. Aluminium has a wide range of applications commonly used in households 
around the world for cookware, foil, antiperspirants, building equipment, pharmaceutical 
drugs such as antacids and is even found at high concentrations in tea. This accounts to a 
great exposure of the metal to both the community and environment.
35-37
 According to the 
Government of Western Australian, Department of Agriculture and Food, just 2-5 ppm 
6 
aluminium is toxic to the roots of sensitive plants and greater than 5 ppm is toxic to tolerant 
species. Acidic soils and waterways can develop within regions of close proximity to 
industrial and mining sites due to acid rain formation. In acidic environments and due to the 
oxyphilic nature of aluminium, aluminium is easily oxidised to aluminium ions where it is 
readily soluble in water, encouraging naturally occurring aluminium oxides to readily be 
absorbed into soils and waterways. This is a major issue for the ecosystem as high 
concentrations of aluminium is toxic to plants, fish, algae and other aquatic organisms.
31,38,39
  
Much research has indicated that aluminium plays a major role in the development of 
neurodegenerative diseases such as AD.
40
 There are counterarguments for this claim of 
aluminium causing AD, however, the debate is still ongoing.
41,42
 As a result, there is currently 
much medical research investigating the potential biological and medical roles aluminium 
plays and therefore the development of new aluminium sensors is of great importance to the 




1.2.1 Alzheimer’s Disease and the ‘Metal Hypotheses’ 
  
AD is a complex, multifaceted neurological disorder and is the most common cause of 
dementia in the western world. According to Dementia Australia, it is estimated that in 2018 
there are 436, 366 people in Australia living with AD. Due to an aging population, this is 
expected to more than double in the next fifty years. AD is also the second leading cause of 
death in Australia accounting for 5.4% of all deaths in males and 10.6% of deaths in females.
 
The pathogenesis of AD is associated with the development of neurofibrillary tangles and 
senile plaque formation. The aggregation of amyloid-beta (Aβ) peptides accounts for the 
development of senile plaques.
44
 Commonly found within these senile plaques are 
coordinated metals such as iron, copper, and zinc. Such metals have been affiliated with 
encouraging the development of Aβ aggregation, particularly when bound to the methionine 
residue 35 (Met-35) of Aβ 1-42.
45
 Iron, copper, and zinc have gained increasing amounts of 
interest in the study of AD due to their roles in provoking oxidative stress in the brain as well 




In AD, iron and 







 can be oxidised by molecules commonly found within 
a healthy brain such as oxygen and hydrogen peroxide. This, in turn, leads to the 
development of reactive oxygen species (ROS) such as the hydroxyl radical (OH•; Fig. 1.2). 
7 
These ROS can then react with biomolecules such as lipids, proteins and nucleic acids within 
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 with hydrogen peroxide yielding the hydroxyl radical, 






The brain is particularly susceptible to oxidative stress as it consumes 20% of the 
body’s total oxygen despite accounting to just 2% of its total mass. Normally, naturally 
occurring antioxidants such as catalase and superoxide dismutase (SOD) prevent the 
generation of oxidative stress, however, as we age this is believed to be less tightly regulated. 
The brain is also a rich source of lipids which can readily react with ROS.
49 
Intracellularly, 
hyperphosphorylation of tau proteins, which form neurofibrillary tangles, is associated with 
oxidative stress.
48
 Hence, there is significant importance for conducting studies which assist 
in the understanding of iron and copper trafficking and their contribution to oxidative stress 
intracellularly.
 
Zinc is a redox-inert metal, with a high binding affinity for proteins, particular 
those consisting of amino acid residues with sulphur donor groups. The majority of biological 
zinc exists within metalloproteins and enzymes such as metallothioneins (MT), zinc finger 
proteins and carbonic anhydrase which are responsible for many vital roles involving 
inflammation, gene expression and metabolism.
50,51
 The brain consists of the highest content 
of zinc compared with any other organ and so in a healthy brain, zinc is tightly regulated.
52 
Oxidative stress induced neurodegeneration may potentially alter zinc metabolism in 
neuronal cells. Glutathione (GSH) is a reducing agent present in up to 5 mM within live cells 
and is primarily responsible for breaking intermolecular disulphide bonds in proteins.
53,54
 In 
an oxidising environment GSH is oxidised to glutathione disulphide (GSSG).
53
 GSSG has 
been shown to liberate zinc from MT (which is a major source of storage for zinc), as well as 
other zinc binding proteins, resulting in a drastic influx of labile zinc.
52
 Due to its strong 
binding affinity to methionine residues, zinc readily coordinates to Aβ proteins resulting in 







1.2.2 Biomedical Inorganic Chemistry   
 
Organic molecules can enhance the medical properties of useful metals. Metals such 
as copper and silver are frequently coordinated to organic molecules which enhances their 
natural antimicrobial properties.
57
 Complexes of gadolinium are used as contrast agents in 
magnetic resonance imaging (MRI).
58
 Large, inert metals such as ruthenium and platinum 
have shown great success in DNA binding and ultimately functioning as anticancer drugs.
59
 
Perhaps the most renowned metal-based drug used for medical applications is cisplatin. 
Cisplatin is a complex of platinum bound in a square planer geometry to two chlorine and 
two amine donor groups with a cis stereochemistry. Cisplatin enters cells where the chlorine 
donors are exchanged for water donor groups. This complex can enter the nucleus where it 
binds to N7 nitrogens of the guanine base on a DNA strand creating a kink and prevent the 
transcription and replication of DNA, ultimately resulting in apoptosis via the p53 pathway in 
rapidly proliferating cells such as cancer cells.
60,61
 Despite the success of cisplatin and other 
platinum-based anticancer drugs, platinum-based chemotherapies have limitations due to 
their adverse side-effects and intrinsic resistance. Therefore, the development of alternative 
organic and inorganic anticancer drugs is imperative to the enhancement of safer, more 
cancer-specific forms of chemotherapy.
62,63
 Lanthanides have been of great intrigue to 
scientists for their magnetic and phosphorescent properties. Their high coordination number 
and strong binding capabilities allow lanthanides to adopt many different coordination 
geometries which can remain intact even after excretion from the human body.
58,64
 Despite 
their vast uses in medical imaging, recent research suggests mild toxicity of lanthanides 
towards organisms.
64,65
 Many research advancements have exploited the properties of 
lanthanides to enhance medical imaging. However, minimal medical research has delved into 
the potential of lanthanides for their application in other medical practices such as anticancer 
agents. This is despite the unique properties which may make complexes of lanthanides ideal 
DNA binders and hence, anticancer drugs.
65
 In general, new developments in biomedical 
inorganic chemistry are currently in demand. Inorganic chemistry provides a plethora of 
different applications in medicinal chemistry within fields that have significant limitations 
which require addressing.  
 
1.3 Design of a Fluorescent Sensor  
 
 In order to design the ideal fluorescent sensor for metal cations, it is important to 
9 
understand and exploit key concepts of fluorescent chemistry. Fluorescence is a phenomenon 
where a molecule is excited by an external source of light followed by an emission of a 
photon due to the excitation of an electron within such a molecule. The mechanisms of 
fluorescence are best described in a Jabłonski diagram also known as the electronic transition 
diagram (Fig. 1.3).  
 
 
Figure 1.3 Jabłonski diagram indicating the quantum processes involved in absorbance, 
fluorescence and phosphorescence. Wavy lines indicate non-radiative processes. S0 and S1 
are the ground and excited singlet states respectively, where electrons remain in a spin up and 
spin down state. T1 indicates the excited triplet state where both electrons are in the spin up 
state. Excited singlet states beyond S1 (ie. Sn; n = >1) are not shown.
66 
 
As a molecule absorbs photons it induces an electron passage from the singlet ground 
electronic level (S0) to an excited state (Sn, n = ≥1) and will return to the ground S0 state via 
the lowest excited state (S1). Some energy is thereby lost in the form of thermal energy to the 
surrounding environment via internal conversion. The electron then transitions from the S1 




1. Intersystem crossing reoccurs where energy is lost by the molecule in the form of non-
radiative heat. 
2. The excited molecule releases its energy to a nearby molecule resulting in the quenching 








3. The energy is emitted as a photon (fluorescence) at a lower energy wavelength compared 
to that of the wavelength that excited the molecule as some energy is always lost as heat 
due to internal conversion. 
4. Intersystem crossing to the triplet (T1) state occurs. T1 is a lower energy state than S1, 
however, is meta-stable and long-lived as triplet state transitions are spin-forbidden and 
thereby the emission of photons has a longer lifetime comparatively to that of 
fluorescence. This phenomenon is referred to as phosphorescence and typically occurs in 




1.3.1 Photo-Induced Electron Transfer (PET) 
       
Photo-induced electron transfer (PET) is a commonly exploited mechanism of action 
which many fluorescent probes exhibit.
69
 PET is a quenching process which involves 
reduction and oxidation between the fluorophore and the receptor of a molecule. In PET, 
electrons from the fluorophore are unable to be excited from the highest-occupied molecular 
orbital (HOMO) to the lowest unoccupied molecular orbital (LUMO). This is due to the 
energy level of the HOMO of the receptor being in-between that of the HOMO and LUMO of 
the fluorophore. This results in the oxidation of the receptor, donating an electron to the 
reduced fluorophore. Ultimately, electrons from the fluorophore are unable to return to the 
ground state as ground state electrons are paired and no fluorescence is produced. When an 
analyte binds to the receptor, the energy of the HOMO of the receptor may then decrease 
below that of the HOMO of the fluorophore. Therefore, fluorescence is re-enabled as no 






Figure 1.4 (a) Electron diagram of the ‘OFF’ state and the (b) ‘ON’ state of a fluorescent 
probe exploiting PET as a means of emitting fluorescence when bound to its analyte. Amber 




1.3.2 Förster Resonance Energy Transfer (FRET) 
 
Förster resonance energy transfer (FRET) is a type of energy transfer which occurs 
within close proximity to an electron donor and acceptor resulting in either fluorescence or 
quenching. FRET can occur when the emission band of the donor and the acceptor’s 
excitement band overlap. The acceptor may, in turn, fluoresce at a lower energy wavelength 
than that of the donor. FRET occurs when a donor molecule is initially excited by an external 
photon when within 1-10 nm of the acceptor. The donor transfers its excited electron to the 
acceptor via a non-radiative transfer where it can relax back to the ground state emitting a 
12 
photon at a lower energy wavelength. This is the primary mechanism in which most 
ratiometric probes function, as one fluorophore acts as a donor, emitting light at shorter 
wavelengths to that of the acceptor fluorophore. Quenching can potentially occur if energy is 





Figure 1.5 Jabłonski diagram representing the mechanism of FRET between two 





1.4 Characteristics of Ideal Fluorescent Sensors in Biological Systems 
 
Different applications of fluorescent sensors alter the specific characteristics which 
deem the sensor to be ‘ideal’. For the sake of this thesis, the applications of the fluorescent 
sensors are designed to sense metal ions that are of intrigue to scientists for their potential 








). These sensors will, therefore, have to be 
suitable for cellular studies using fluorescent microscopy and those that sense metals such as 
13 
aluminium and iron, which also effect the environment, will have to be able to detect such 
metals in different water systems. When designing fluorescent sensors, there are specific 
considerations which make them more practical and therefore more desirable for real-world 
applications. Some of these are listed below: 
 
1. Financial Suitability 
 
The metal sensors being designed are ideally needed to be suitable for mass 
production. Therefore precursors are required to be inexpensive and synthetic pathways need 
to be short, simple and produce high yields.
75 
 
2. Biologically Innocuous 
 
As these sensors are to be required for biological practices, they need to be innocuous 
to living organisms. Molecules are also further desired if the precursors are biologically 
innocuous in case degradation occurs. 
 
3. Water Solubility yet Membrane Permeable 
 
As the environment of living organisms is always aqueous, it is essential for 
fluorescent sensors to be water soluble whilst also being able to cross the phospholipid 
bilayer of the cellular membrane. With animal cells which do not consist of a cell wall, this 
can be achieved by designing organic molecules consisting of hydrophilic moieties such as 
amines, hydroxyls and carboxylic acids. Otherwise, when molecules are dissolved in 
dimethyl sulphoxide (DMSO) they can become permeabilised, however, high concentrations 




Sensors must have selectivity towards the analyte they are detecting, at least at the 
emission wavelength it is detecting it at. This can be achieved by using binding groups that 
are specific to the analyte it is designed to sense. This is not always easily achievable as 
binding groups will have many different binding partners which compete with the desired 
analyte. This can result in an insufficient amount of fluorescence enhancement, quenching of 
14 
fluorescence or even multiple different analytes creating a similar fluorescent response. The 
analyte also needs to have a high binding affinity towards the probe to ensure they do not 
competitively bind with biomolecules such as GSH. 
 
5. Observable Amount of Fluorescent Output 
 
The change in fluorescence, either by a shift in emission or fluorescent enhancement, 
needs to be sufficient enough to be distinguishable from the unbound probe. The brightness 
of the probe also needs to be able to be distinguished from background noise and in 
fluorescent microscopy, reduce the intensity of the laser power which can potentially be 
harmful to cells. The quantum yield (ɸ) can be measured from comparing the amount of light 
absorbed to the amount of light emitted to indicate the efficiency of the probe. Quantum yield 











6. Excitation at Lower Energy Wavelengths  
 
Fluorescent probes that excite at lower energy wavelengths are ideal to reduce 
damage to DNA and proteins in cells as well as reduce auto-fluorescence due to near 
ultraviolet (UV) excitation of fluorescent biomolecules such as tryptophan, flavins and 





It is essential that fluorescent probes are less prone to degradation that may occur due 
to the high-intensity lasers used to excite the sensor. Great photostability increases the time 
experimentation can occur and ensures that fluorescent intensity is consistently high enough 
to evoke sufficient detection.  
 
8. Sufficient Difference in Excitation and Emission Wavelength 
 
Self-quenching can occur when there is an overlap between the excitation and 
emission bands due to re-absorbance of emitted light by neighbouring molecules. A larger 
15 
difference in energy between the excited to emission band (Stokes shift) is therefore preferred 




Figure 1.6 Representation of excitation and fluorescence bands overlapping (indicated in red) 





The most desired fluorescent sensors give responses that are ratiometric. This is 
where the probe alone emits at a specific wavelength of light different to that of the analyte 
bound to the probe. Therefore the analyte can potentially be quantified by comparing the 
fluorescent intensity from the emission of the probe compared to that of the emission 
intensity of the analyte bound to the probe. Ratiometric probes are also able to be tracked as 
to whether and where they migrate intracellularly. This is important as organelles such as the 
cell nucleus, mitochondria and chloroplasts are enclosed by a membrane. If a probe is unable 
to enter into all compartments of cells then it may not be able to sense its desired analyte.  
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1.5 Choice of Ligands 
 
1.5.1 Schiff Bases as Fluorescent Sensors for Detecting Metal Ions 
 
A Schiff base condensation reaction results with the deamination of a primary amine 
by a carbonyl, yielding water and a Schiff base with an imine moiety (Fig. 1.7). Schiff base 
condensation reactions are frequently conducted by chemists, especially among 
supramolecular chemists, because of their ease of synthesis, high yields, strong 
coordinative ability and a vast amount of applications to various scientific fields including 
medicine as anticancer and antimicrobial agents.
78-80
   
 
 
Figure 1.7 Schiff base condensation reaction. R and R1 groups denote to carbon substituent. 




Among their many applications, Schiff bases have been widely recognised as 
exceptional chemosensors. Schiff bases are frequently used as selective ‘turn-on’ 
fluorescent probes with a large amount of fluorescent output, especially for metals such as 
aluminium and zinc ions. Such Schiff base probes often incorporate PET as a mechanism 
of fluorescent enhancement due to the resonance of the lone pair electrons upon the imine 
moiety.
81-83
 Schiff bases are also frequently found as fluorescent enhancement as well as 
quenching probes in the presence of copper and iron ions.
82,84,85
 These four metals (Al, Fe, 
Cu and Zn) are of immense intrigue due to their roles in developing the neurodegeneration 
associated with AD. Schiff bases decompose in aqueous solutions due to hydrolysis. 
Studies have however indicated that decomposition is halted by the coordination of metal 
ions, resulting in stable complexes not only in water but also in high-intensity light. 
Regardless, when designing Schiff bases for biological applications considerations should 
be made to ensure non-toxicity of not only the Schiff base, but also the precursor 
17 
molecules. With this in mind, Schiff bases have been successfully used for biological 
purposes and have had little effect on cell viability.
1,2,79,86
 Due to the relative ease of 
synthesis, strong coordinative ability, photostability and ability to selectivity sense 
biological metal ions with high fluorescent intensity, Schiff bases make the ideal design for 
a practical fluorescent probe. 
 
1.5.2 The Chosen Ligands 
 
The chosen ligands in this thesis report that will be analysed in chapters two, three 










 is a promising PET induced Al
3+
 fluorescent enhancer with ideal applications for 
confocal studies due to its high sensitivity, non-toxicity and significant blue-shift in 
fluorescence when bound to its analyte. H2L
I
 is easily synthesised via a Schiff base 
condensation reaction between L-tryptophan and 4-diethylamino salicylaldehyde and 















) display great potential as anticancer drugs. H3L
II 
also has some potential as a Zn
2+
 
fluorescent sensor, however, due to its low half maximal effective concentration (EC50), is 
not ideal as a fluorescent sensor. Thereby, H3L
II 
is coordinated to trivalent lanthanides to 
observe the potential use of H3L
II 
and its lanthanide complexes as anticancer agents upon an 
array of different cell lines. Cell viabilities of H3L
II
 are compared to the lanthanide 
complexes to evaluate the suitability of lanthanide complexes as anticancer drugs. H3L
II 
and 
its complexes are further studied using spectral techniques to demonstrate their ability to bind 
to calf thymus DNA (ctDNA). H3L
II
 is synthesised from L-ornithine and two equivalents of 
2-hydroxy-1-naphthaldehyde via a Schiff base condensation reaction and its lanthanide 











 in a 1:1 stoichiometry resulting in a high amount of sensitivity. H3L
III 
is 
also very photostable, has a very low limit of detection (LoD) and has strong immunity to 
hydrolysis in aqueous conditions. H3L
III 
is synthesised from the Schiff base condensation 
reaction between L-cysteine and 2-hydroxy-1-naphthaldehyde.  
18 
1.6 Aims and Scope 
 
This project aimed to design and synthesise amino acid-derived Schiff base ligands 
for the purpose of detecting metal ions implicated in the pathogenesis of AD. Initially the 
ligands were designed, synthesised and characterised. The ligands then underwent 
fluorescent and colourimetric assessments to determine if they could act as metal sensors. 
Ligands that were selective to biometals were then screened for their biocompatibility using 
cell viability assays. Ligands with little or no effect on cell viability were then further 
investigated for their potential application as fluorescent sensors whereas ligands with high 
cytotoxicity were coordinated to lanthanide ions and studied for further anticancer and DNA 




Figure 1.8 Flowchart of the steps that were conducted in order to present the research in this 
thesis report.  
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Chapter 2 – L-Tryptophan-Derived, Water-Soluble Schiff Base as a Blue-
Shift Fluorescent Sensor for Detecting Al
3+





2.1 Abstract  
 
Aluminium is the most abundant metallic element in the Earth’s crust. Within acidic 
environments, oxyphilic aluminium forms into aluminium oxides where it is readily 
solubilised in water and potentially toxic to many lifeforms. Recent studies have correlated 
aluminium with the development of Alzheimer’s disease (AD); however, much research has 
also contradicted these claims. Due to such reasons, much research is currently investigating 
the roles aluminium plays in biological systems. Fluorescent sensors provide an imperative 
tool in investigating the roles of metals (such as aluminium) in biological systems. However, 
current fluorescent probes of aluminium exist with major limitations including negative 
effects on cell viability and a general lack of biological analysis. Herein, ligand (H2L
I
) is 
synthesised and characterised via a Schiff base condensation reaction between L-tryptophan 
(a fluorescent amino acid) and 4-diethylamino salicylaldehyde to a yield of ~70%. Water-
soluble H2L
I 
exhibits a blue-shift from 533 nm to 405 nm when bound to its Al
3+
 analyte 
which is detectable even in the presence of other potentially interfering metal ions. H2L
I 
exhibits a limit of detection (LoD) of 61.5 nM and a 1:2 ligand-to-metal stoichiometry is 
determined. H2L
I 
is observed to be non-toxic from up to 500 µM and is able to sense for Al
3+
 





Aluminium constitutes to 8.3% of the lithosphere by mass and is the ninth most 
abundant metal in humans.
1,2
 Its toxicity towards agriculture and humans is of immense 
intrigue to scientists in environmental and medical fields. Aluminium is prevalent in utensils 
within common workplaces and households, it is also abundantly found in pharmaceuticals 
such as antacids, as well as in cosmetics such as antiperspirants. These factors result in a high 
exposure of aluminium to both humans and the environment.
3-5
 Solid aluminium readily 
oxidises into aluminium oxides in acidic environments where it becomes highly water-
soluble and
 
toxic to wildlife within aqueous environments.
6-8
 According to the Department of 
Agriculture and Food, Western Australian Government, a low 2-5 ppm of Al
3+ 
is toxic to the 
roots of aluminium-sensitive plants. This is of particular concern to regions such as Western 
Australia where high levels of mining and agriculture coexist, resulting in a high exposure of 
toxic, water-soluble Al
3+
 to soils and crops due to acid rain formation. 
 
Aluminium has recently gained much interest in the field of medicine due to its 
apparent effects on the development of AD.
9
 Aluminium’s role in AD is, however, frequently 
disputed and therefore the development of new research tools is imperative to augment the 
understanding of the biological behaviours and influences of the metal.
10-12 
The use of 
fluorescent sensors have been abundantly used as effective tools in the study of different 
metal ions in biological systems. In biology, fluorescent sensors are favoured over other 
chemosensory techniques due to their significant sensitivity and ability to be detected through 
cellular membranes.
13,14
 Current aluminium sensors come with significant limitations. For 
example, some have low selectivity for Al
3+
 and others often lack practicality due to 
complicated and expensive synthetic procedures, poor water solubility, poor fluorescence 
intensity and some are cytotoxic or decompose into cytotoxic compounds (Table 2.1).
15,16
 
Therefore, there is a great demand for the development of new fluorescent sensors with 
optimised characteristics and enhanced practicality for the detection of Al
3+
 in aqueous 




) is synthesised via a Schiff base condensation reaction between 




CNMR, Electrospray Ionisation - High Resolution Mass Spectrometry (ESI-HRMS), FT-
IR, simultaneous thermal analysis (STA), powdered X-ray diffraction (P-XRD) and Single 
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crystal X-ray diffraction (SC-XRD). H2L
I 
has been designed for its practicality as it is 
synthesised with a high yield by a simple one-step synthesis from biocompatible precursors. 
L-tryptophan is an essential amino acid commonly known as the precursor for the 
neurotransmitters melatonin and serotonin and is also used as a fluorescent biomarker for 
proteins.
17,18
 4-Diethylamino salicylaldehyde is another biologically derived precursor 
frequently sourced in metallo-supramolecular chemistry for its strong metal binding potential 







for its potential application as a fluorescent sensor for the 
detection of Al
3+ 
in different biological, environments. Fluorescent analysis is used to 
demonstrate the potential of H2L
I
 as a sensor for Al
3+
 and determine its LoD. Cell viability 
assays determine the suitability of H2L
I 
to be used in biological application. Finally, H2L
I 
is 
then applied to an array of biological environments to demonstrate its application in cellular 




Table 2.1 Recent literature examples of nanomolar Al
3+
 fluorescence detecting probes. 
















buffer (pH = 7.4)  








EtOH Yes 20 None N/A N/A N/A 14. 










DMSO Yes N/A None N/A N/A N/A 16. 
DMSO Yes N/A None N/A N/A N/A 16. 
MeOH/H2O (1:9, 
v/v) acetate buffer 
(pH = 4.5) 
Some 
fluorescence 




None N/A N/A N/A 25.  
Ethanol Yes 100 None N/A N/A N/A 26.  
MeOH, Tris 









v/v), HEPES (pH 
= 7.4) 
Yes, no spectra 
of the 
screening of 
metals is given 









with Zn2+ and 
Cd2+ 








82.8 None N/A N/A N/A 30. 
EtOH Yes ‘100’ 
level 





with Fe3+ and 
Cr3+ 
122 None No effect 
on cell 
viability 
up to 40 
µM 






Yes 299 None No effect 
on cell 
viability 
up to 40 
µM 




EtOH Yes 3 None N/A N/A N/A 33. 
EtOH Yes 5 None N/A N/A N/A 33. 
MeOH/H2O (1:1, 
v/v), HEPES (pH 
= 7.4)  




H2O Yes N/A N/A ~50% 
viability at 
100 µM 




EtOH Yes ‘100’ 
level 
None N/A N/A N/A 36. 
H2O, GSH, 
HEPES (pH = 
7.4) 
Yes 61.5 From 533 nm 














2.3 Results and Discussion  
 





was synthesised from the condensation of L-tryptophan and 4-diethylamino 
salicylaldehyde under reflux for 24 h in ethanol upon the presence of a catalytic amount of 
glacial acetic acid (Fig. 2.1). It was then characterised via 
1
H NMR and 
13
CNMR, ESI-
HRMS, FT-IR, STA and P-XRD. SC-XRD demonstrates that H2L
I 
crystallises in the 
orthorhombic space group with cell dimensions of a = 10.0820 (19) Å, b = 12.490 (2) Å, c = 












was initially characterised for its absorbance in a UV-visible (UV-vis) 
spectrophotometer spectrum indicating a peak maxima of 379 nm. H2L
I 
was then scanned in 













. A fluorescent spectrum of H2L
I 
was obtained when excited at 358 nm 
indicated a broad yet mild fluorescence peak at 533 nm (green) H2L
I
 was then scanned in the 
28 
presence of various metal ions (2 eq.). A significant fluorescent enhancement response of 
~24-fold is observed at 405 nm when H2L
I 
is in the presence of Al
3+
 (2 eq.). A very weak 
fluorescent enhancement is also exhibited at 405 nm when in the presence of Zn
2+
 (2 eq.). 
Weak quenching of H2L
I
 occurs at 533 nm when in the presence of Co
2+
 (2 eq.) and Fe
3+
 (2 
eq.). Results demonstrate that H2L
I 
has a significant and selective fluorescent response to Al
3+
 
over other metal ions. H2L
I 





observed slowly interacting with Al
3+ 
as a function of time where fluorescence intensity 
plateaued at ~60 min and slowly depreciated likely due to damaged caused by the excitation 




Figure 2.2 The fluorescence spectrum of H2L
I
 (20 µM) in the presence of various metal ions 
(2 eq.) in 20 mM HEPES, 5 mM GSH water solution at pH = 7.4. Inset: A scatter plot of the 
fluorescence of H2L
I
 (20 µM) in the presence of 2 eq. Al
3+
 in 20 mM HEPES, 5 mM GSH, 
Milli-Q water solution at pH = 7.4, as a function of time (0-180 min). 
 












with other metal ions 
can be observed under the naked eye when excited with ultraviolet (UV) light. As observed 
H2L
I
 emits light at a blue/ purple colour in the presence of Al
3+
 which is substantially 








 This pronounced fluorescent enhancement of H2L
I 
at 405 nm when in the presence 
of Al
3+
 displays its high selectivity.  It may be explained that the lone pair of electrons from 
the imine nitrogen atom of the Schiff base may evoke contributions to the photo-induced 





chelates to the strongly bound, diamagnetic Al
3+
, the quenching is 





Figure 2.3 Detection of Al
3+
 by the naked eye using H2L
I
 (20 µM) and H2L
I
 in the presence 
of a series of metal cations (2 eq.) under UV light (365 nm) in 20 mM HEPES, 5 mM GSH, 
Milli-Q water solution at pH = 7.4 
 
2.3.4 Competing Metal Ion 
 




 in the coexistence of other metal ions was 
conducted in order to determine the ability of H2L
I
 to sense Al
3+
 in the presence of potentially 











 displayed some quenching, 
however, the fluorescent intensity was still increased by ~14-fold, ~3.2-fold and ~12.5-fold 
respectively, which are all still clearly detectable. All other metal ions observed very minimal 






Figure 2.4 Fluorescence intensity of H2L
I
 (20 µM) with Al
3+
 (2 eq.) under the coexistence of 
other metal cations (2 eq.) in 20 mM HEPES, 5 mM GSH, Milli-Q water solution at pH = 
7.4. The samples were excited at 358 nm and fluorescent intensities were recorded at 405 nm. 
 
2.3.5 Limit of Detection (LoD) 
 




(20 µM) was conducted in methanol which 
determined the limit of detection (LoD) of H2L
I 
where fluorescent intensities were recorded 
at 405 nm upon 358 nm excitation. Methanol was used alternately to the water, to reduce 
interference from the buffer solution, as well as, to prevent decomposition due to hydrolysis. 
Both of which would have inaccurately interfered with LoD and stoichiometry 
measurements. The titration determined a LoD of 61.5 nM and a limit of quantification (LoQ) 
of 204.9 nM determined by the equations 3σ/m and 10σ/m respectively. The metal titration 





Figure 2.5 Fluorescence titration of H2L
I
 upon addition of increasing amounts of Al
3+
 (0-5 
eq.) in methanol. Inset: Fitting of the fluorescence titration curve of H2L
I
 in methanol. LoD = 
61.5 nM and LoQ = 204.9 nM determined by the following equations 3σ/m and 10σ/m 
respectively. 
  
2.3.6 Job’s plot 
 




in methanol to a total concentration of 





intensities were excited at 358 nm and recorded at 405 nm. The Job’s plot molar intersect of 
0.67 matched data from the MS and titration indicating a 1:2 ligand-to-metal stoichiometry 








 in methanol at λmax = 405 nm. Intersect of linear plots 
at molar fraction of 0.67, indicating a 1:2 ligand-to-metal stoichiometry. 
 




 crystallises in the orthorhombic space group P212121, with a single molecule  
present in the asymmetric unit (Fig. 2.7). Solution in a chiral space group indicates that only 
one isomer is present in the crystal lattice and upon inspection of the chiral carbon (C10) the 
S isomer was found to have solely crystallised. Intramolecular hydrogen bonding (N2
…
O3 
distance of 2.706 Å) between a protonated imine donor (N2) and a phenolic acceptor (O3) 
stabilises the phenolic, imine and carboxyl groups to lie in the same plane. The R-group of 
the L-tryptophan precursor is directed almost perpendicular to the plane mentioned above. 
This arrangement is stabilised by an extensive three-dimensional array of intermolecular 
hydrogen-bonding and edge-to-face π-π interactions (N1
…
O1 – 2.930 Å, O1
…
O3 – 2.510 Å 
and H00N
…
C13-C14-C15-C16-C17-C18 centroid – 2.36 Å). (Fig. 2.8 and 2.9) 




Figure 2.7 Schematic representation of the single S enantiomer present in the asymmetric 
unit of H2L
I




Figure 2.8 Schematic representation of the inter- and intramolecular hydrogen-bonding 
interactions present in the crystal lattice of H2L
I
. Hydrogen-bonds are represented by blue 





Figure 2.9 Schematic representation of the intermolecular edge-to-face π-π interactions 
present in the single crystal X-ray structure of H2L
I
. Intramolecular contacts are represented 
by blue cut lines. 
 
Table 2.2 Crystallographic details of H2L
I
. 
Empirical formula  C22H24N3O3  
Formula weight  379.45  
Temperature/K  100.55  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  10.0820(19)  
b/Å  12.490(2)  
c/Å  15.926(2)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å
3
  2005.5(6)  
Z  4  
ρcalcg/cm
3
  1.257  
μ/mm
-1
  0.085  
F(000)  808.0  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  4.782 to 50.044  
Index ranges  -11 ≤ h ≤ 12, -14 ≤ k ≤ 14, -18 ≤ l ≤ 18  
Reflections collected  28096  
Independent reflections  3530 [Rint = 0.1529, Rsigma = 0.0846]  
Data/restraints/parameters  3530/0/257  
Goodness-of-fit on F
2
  1.070  
Final R indexes [I>=2σ (I)]  R1 = 0.0527, wR2 = 0.1091  
Final R indexes [all data]  R1 = 0.0699, wR2 = 0.1166  
Largest diff. peak/hole / e Å
-3
  0.43/-0.28  
Flack parameter -1(2) 
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2.4 Applications in Biological Systems 
 
2.4.1 Detection of Al
3+
 in Different Water Samples 
  
At a consistent concentration of H2L
I
 (20 µM), water samples of Milli-Q, tap, Cattai 





indicated strong fluorescent enhancement responses for Al
3+ 
in Milli-Q 
at low concentration (10 – 20 µM), however, at higher concentrations (50 - 200 µM) this was 
reduced. This reduction of fluorescent intensity at higher concentrations may be due to self-
quenching, interactions with the solvent or lower pH due to stock solutions of Al
3+
 being 
stored in acidic conditions to avoid oxide formation.
39
 This same phenomenon occurs in tap, 
Cattai Creek and Redbank Creek at > 100 µM, 100 µM and 50 µM respectively. Overall, 
H2L
I 
has the ability to sense for Al
3+
 in different water samples, despite some limitations 
which may be due to experimental error.  
 
 
Figure 2.10 Fluorescent response of H2L
I
 (20 µM) in the presence of different concentrations 
(0-200 µM) of spiked Al
3+ 
in Milli-Q water (a.), tap water (b.), Cattai Creek water (c.) and 
Redbank Creek water (d.) as well as the fluorescence of the respective water samples with no 
treatment. The samples were excited at 358 nm and fluorescent intensities were recorded at 
405 nm.   
 
36 
2.4.2 Cell Viability Assay 
 
A cell viability assay of H2L
I
 was conducted at varying concentrations using the MTT 
reductase method in 1321N1 astrocytoma cells to determine the suitability of H2L
I 
for 
biological studies. Results indicated that up to 500 µM, H2L
I 
exhibited no effect on cell 
viability implying the suitability of H2L
I 
to potentially sense Al
3+
 in biological systems. 
Minor variations in cell viability are likely due to varying rates of cell growth and/ or 




Figure 2.11 Percent (%) cell viability of 1321N1 astrocytoma cells treated with varying 
concentrations (0–500 μM) of H2L
I
 for a 24 h incubation period, determined by an MTT 
reduction assay. Error bars = STD (n = 6). 
 
2.4.3 Cellular Imaging 
 
Fluorescent microscopy studies displayed the ability of H2L
I
 to detect Al
3+
 in 1321N1 
astrocytoma cells under UV light. In control groups of cells in 1: 6.67 (v/v) DMSO, 
37 
phosphate buffered saline (PBS) with no additional treatment, cells observed no fluorescent 
enhancement. Some fluorescence was observed in cells treated with H2L
I 
(150 µM) 1:6.67 
(v/v), however, this fluorescence was not significant. Upon addition of H2L
I 
(150 µM), 
significant fluorescence enhancement occurs within the cell lines spiked with AlCl3 (300 µM) 
1: 6.67 (v/v). H2L
I 
appears to detect Al
3+
 localised around the nuclear membrane of 1321N1 
astrocytoma cells (Fig. 2.12). 
 
 
Figure 2.10 Fluorescent microscope images of 1321N1 astrocytoma cells. a), b) and c) 
indicate bright-field images of the cells. Images labelled d), e) and f) are the fluorescence 
images. Images g), h) and i) indicate overlay images. Cells labelled a), d) and g) are control 
groups of 1: 6.67 (v/v) DMSO, PBS buffer. Images b), e) and h) are cells spiked with 150 µM 
H2L
I
 in 1: 6.67 (v/v) DMSO, PBS buffer. Images c), f) and i) indicate samples of 150 µM 
H2L
I 
and 300 µM AlCl3 in 1: 6.67 (v/v) DMSO, PBS buffer solution. All experiments were 









was successfully synthesised and characterised. H2L
I 
displayed a significant, 
selective, fluorescent enhancement response to Al
3+
 at 405 nm and H2L
I 
itself indicated mild 
fluorescence at 533 nm. A stoichiometry of 1:2 ligand-to-metal ratio was indicated using 




 was tested in the 
coexistence of other metals and in different water samples indicating that H2L
I 
can sense for 
Al
3+
 in various environments. Cell viability assays indicate that H2L
I 
has no effect on cell 
viability and thus is suitable for cellular studies. H2L
I 
was thereby tested for its potential 
fluorescent sensing capabilities in cellular conditions, using a fluorescent microscope. Here, 
H2L
I 
indicated that it can sense intracellular Al
3+ 




was also compared to an array of different Schiff base fluorescent Al
3+
 sensors 
where it displayed significant specificity for detecting Al
3+
 in biological systems in contrast 
to other Schiff base sensors.   
 
2.6 Experimental  
 
2.6.1 Chemicals and Reagents  
 
All chemicals, solvents and cell lines were purchased from commercial sources of 
commercial grade and used without further purification. All aqueous solutions were prepared 
































) or nitrate (Pb
2+
) salts of analytical grade, then standardised using literature 













NMR spectra were measured on a Bruker DRX-300 NMR spectrometer. FT-IR 
measurements were conducted on a Bruker Vertex 70 spectrometer. Electrospray ionisation 
High-resolution mass spectra (ESI-HRMS) were collected using a Waters Xevo QToF 
quadrupole mass spectrometer with samples dissolved in methanol. Simultaneous thermal 
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analysis (STA) was undertaken on a Netzsch STA449 C Jupiter thermo-microbalance. An 
Edinburgh instruments FS5 Spectrofluorometer was used to conduct all fluorescent 
measurements. Agilent Cary 100 spectrophotometer was used to conduct the UV-vis 
experiments. Quartz cuvettes with a 1 cm optical path length were used for all fluorescent and 
colourmetric experiments.  Fluorescent and colourimetric measurements, as well as cell 
viability assays, were graphed using Origin Pro 9.0. Scanning electron microscopy–electron 
dispersive spectroscopy (SEM-EDS) analysis was conducted on a Phenom XL instrument. 
Samples were run at 15 kV at medium vacuum without surface coating. Crystallographic 
data was collected using a Bruker kappa-II CCD diffractometer at 100 K, employing an IµS 
Incoatec Microfocus Source with Mo-Kα radiation. Data integration and reduction was 
undertaken with CrysAlisPro.40. The structures were solved by direct methods and the full-
matrix least-squares refinements were carried out using a suite of SHELX programs via the 
Olex interface. Non-hydrogen atoms were refined anisotopically. Hydrogen atoms were 
included in idealised positions and refined using a riding model. 
 
2.6.3 Synthesis of H2L
I 
 
L-tryptophan (538 mg, 2.66 mmol) and 4-diethylamino salicylaldehyde (510 mg, 2.66 
mmol) was dissolved in ethanol (25 mL) into a round bottom flask. Five drops of glacial 
acetic acid then added to the mixture. The mixture was then stirred under reflux at 90 °C for 
24 h. The precipitate was then collected whilst hot using gravity filtration and wash 
thoroughly in methanol and then diethyl ether. The precipitate was left to dry overnight 
resulting was a brown/ yellow powder with a yield of ~70%. Crystals suitable for SC-XRD 
were grown by slow evaporation of H2L
I 
(100 mg, 0.264 mmol) in 10 mL methanol. m.p. 
221.6 °C, 
1
HNMR: (300 MHz, DMSO-d6 with TMS) δ 10.892 (s, 1H, NH), δ 7.979 (s, 1H, s, 
1H, N=CH), δ 7.5624 (d, J = 7.62 Hz, 1H, ArH), δ 7.317 (d, J = 8.17 Hz, 1H, ArH), δ 7.0697-
6.9227 (m, 4H, ArH), δ 6.1631 (d, 8.17 Hz, 1H, ArH), δ 6.0156 (s, 1H, ArH), δ 4.2428 (t, J = 
5.73 Hz, 1H, CH), δ 3.3265 (q, J = 6.64, 4H, CH2), δ 3.1499 (dd, J = 8.29, 1H, CH2), δ 
1.0672 (t, J = 6.64 Hz, 6H, CH3). 
13
CNMR: (75 MHz, DMSO-d6 with TMS) δ 172.670, δ 
164.455, δ 164.251, δ 151.285, δ 136.222, δ 135.976, δ 135.380, δ 127.089, δ 123.681, δ 
120.799, δ 118.232, δ 111.245, δ 109.693, δ 107.339, δ 102.993, δ 97.093, δ 69.406, δ 









 (O-H, carboxylic acid), 2900.91 cm
-1
 (O-H, phenol), 1593.70 cm
-1
 (O=C, 
carboxylic acid), 1520.28 cm
-1
 (C=N). UV−vis (1 cm optical path length, Milli-Q H2O, 5 mM 
40 
glutathione (GSH), HEPES 20 mM, pH = 7.4): 20 μM H2L
I
, λmax = 379 nm (abs = 0.830, ε 
= 41 500). 
 






Potassium hydroxide (44.4 mg, 0.791 mmol) was dissolved in 10 mL methanol. H2L
I 
(100 mg, 0.264 mmol) was completely dissolved in the mixture and filtered. The filtrate was 
then collected and stirred at 100 °C for 5 min. Aluminium chloride (70.4 mg, 0.528 mmol) 
was dissolved in 10 mL methanol and added dropwise to the mixture. The mixture was then 
stirred for a further 2 h and filtered. The filtrate was then collected and rotary evaporated 
until dry. 20 mL of Milli-Q water was added and the precipitate was collected via filtration 
and washed with ice-cold methanol and dried overnight resulting in a bright yellow powder at 













 (O-H, carboxylic acid), 2900.91 cm
-1
 (O-H, phenol), 1593.65 cm
-1
 




2.6.5 Fluorescent and UV−Vis Spectroscopy  
 
A stock solution of H2L
I
 (2 mM) was prepared in Milli-Q water at ~7.4 pH; this 
solution was used for all spectroscopic experiments except limited detection and Job’s plot 
experiments which were conducted with a stock solution of H2L
I 
(1 mM) in methanol. Other 
water-based solutions were trailed for limited detection and Job’s plot experiments. However, 
due to interaction with an array of buffer solutions, as well as, decomposition of the ligand, 
pure methanol was used as a non-interfering media. Metal interaction experiments were 
carried out by aliquoting appropriate volumes of H2L
I
 stock solution to 20 µM and metal ions 
to 40 µM (2 eq.) in mimicked intracellular conditions of 20 mM glutathione (GSH), 5 mM 
HEPES buffer at 7.4 pH in Milli-Q water to a total cuvette volume of 3 mL.
41
 AlCl3 was 
added as 2 eq. (40 µM), with competing metal ions also as 2 eq. (40 µM). Job’s plot 




 and AlCl3 
were prepared in various molar ratios, with the combined concentration of both at 25 μM to a 
total cuvette volume of 3 mL. These molar ratio mixtures were prepared in a methanol to 
reduce external interactions with H2L
I
 and AlCl3. All fluorescent studies were excited at 358 
nm, scanned from 368-700 nm and were prepared ~12 h prior to running, where they were 
stored in a dark, dry environment at standard laboratory conditions. Mimicked intracellular 
41 
solution studies were performed at slits of ex/em = 3/3 nm, whereas methanolic studies at 
ex/em = 1.25/1.25 nm.   
 










 a metal titration approach was used in 
methanol, where samples of H2L
I
 (20 µM) was prepared with a various equivalents of AlCl3. 
The samples were left to incubate in a dark, dry environment at standard laboratory 
conditions for ~12 h prior to run time. The limit of detection (LoD) and limit of 
quantification (LoQ) were calculated using 3σ/m and 10σ/m, respectively, where σ is the 
standard deviation of a blank solution and m is the slope of the linear plot obtained.
44
 For the 
standard deviation (σ) determination, we took 10 repeated spectra measurements of a blank 
solution (H2L
I
 solution in the same conditions used for measurements but without any 
addition of AlCl3) and calculated the standard deviation for the fluorescent values at 405 nm, 
obtaining a value of σ = 168.5. 
 
2.6.7 Cell Culturing 
 
Human 1321N1 cell line (1321N1 astrocytoma; purchased from Sigma-Aldrich/ 
ATCC) were grown in Dulbecco's modified eagle medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and antibiotics (penicillin-100 µg ml
−1
; streptomycin-50 µg ml
−1
). 
Cells were cultured at 37 °C in a 95% air, 5% CO2 incubator. 
 
2.6.8 Cell Viability Assay 
 
1321N1 astrocytoma cells were seeded into a 96-well plate and filled with complete 
DMEM to a total volume of 190 µL containing 10,000 cells each and then incubated (37 °C, 
CO2 5%) for 24 h. Stock solutions of H2L
I
 (10 mM, 5 mM, 1.25 mM) were prepared in sterile 
Milli-Q water at 7.4 pH. 10 µL of sextet concentration of 0, 20, 50, 100, 150, 200, 300, 350, 
400 and 500 µM of H2L
I
 were prepared into the 96 well plates and incubated for 24 h. 50 µL 
of 5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added 
into each well and the cells were then left to incubate (37 °C, CO2 5%) for a further 2 h. The 
media was decanted from each well and 100 µL of DMSO was added into each well to 
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solubilise the formazan crystals. The 96 plate well was gently agitated before optical 
absorbance was measured at 595 nm using the BMG FLUOstar OPTIMA microplate reader. 
The values were then calculated as the mean ± standard deviation errors of six independent 
experiments. The cell viability was expressed as the optical density ratio of the treatment 
compared to control samples.   
 
2.6.9 Detection of Al
3+
 in Different Water Samples 
  
Water samples were taken from type I water from a Milli-Q water purification system, 
tap water from Parramatta Council, Sydney, NSW, Australia. River water samples were 
collected from still river water samples of Cattai Creek, The Hills Shire Council, Sydney, 
NSW, Australia and Redbank Creek, Hawkesbury Shire Council, Sydney, NSW, Australia. 
Blank water samples were initially measured as controls. H2L
I 
(20 µM) was added into 
varying spiked samples of AlCl3 (0, 10, 20, 50, 100 and 200 µM) to a total volume of 3 mL in 
each of the water samples. All water samples were excited at 358 nm and data was collected 
at 405 nm with slit sizes of ex/em = 3/3 nm.    
 
2.6.10 Cell Imaging 
 
1321N1 astrocytoma cells were viewed under a Leica DMRBE Trinocular Research 
Microscope with all parameters according to table 2.3. Samples of live 1321N1 astrocytoma, 
1321N1 astrocytoma upon addition of H2L
I
 (150 µM), and H2L
I 
(150 µM) in the coexistence 
with AlCl3 (300 µM) were prepared on separate slides, excited under a UV lamp and viewed 
with an objective lens at 100 x magnification, 50 µm. All cellular environments were 
incubated in DMSO, PBS buffer (1: 6.67 v/v ratio respectively) at 37 °C, CO2 (5%) for 30 




Table 2.3 Parameters used for all fluorescent cell imaging studies of 1321N1 astrocytoma 
cells. 
Dimension Logical Size 
Physical 
Length 
Physical Origin Voxel Size 
X 1296 pixels 97.13 µm 0.00 µm 0.075 µm 
Y 966 pixels 72.38 µm 0.00 µm 0.075 µm 
 
LUT Name Exposure Time Gain Resolution XY Resolution Z 
Grayscale 820.025 ms 5.6 0.258 µm 0.494 µm 
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2.10 Supplementary Information 
 
Figure S2.1 The STA data of H2L
I
 (40-590 °C). 

















Figure S2.2 Simulated (top) vs experimental (bottom) powder X-ray diffraction data of H2L
I
, 




Figure S2.3 The 
1
HNMR spectrum of H2L
I
 in DMSO-d6. 
 
Figure S2.4 The 
13
CNMR spectrum of H2L
I
 in DMSO-d6. 
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 in methanol from 50 – 800 m/z. Inset: On the 
left, the structure and molar mass of H2L
I
. On the right, the predicted (above) and 














 in methanol from 50 – 800 m/z. 






On the right, the 


















Figure S2.9 EDS spectrum of H2L
I
. Inset: At the top, the elemental composition of H2L
I
 and 
on the right, backscattered SEM micrograph of H2L
I 
at 500 x magnification. 
 





















 in the 
presence of various metal ions. 
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Chapter 3 – The Metal Binding and Anticancer Properties of Lanthanides 







Despite being the focal point of much medicinal research, the high prevalence and 
fatality rate of cancer-related illnesses demonstrates the difficulty in finding appropriate 
cancer treatments. Minimal research has explored the potential of lanthanide-based inorganic 
complexes for their application as anticancer agents despite the unique properties which may 
make complexes of lanthanides ideal deoxyribose nucleic acid (DNA) binders and hence, 
anticancer drugs. Herein, ligand (H3L
II
) is synthesised via a Schiff base condensation reaction 
between L-ornithine and 2-hydroxy-1-naphthaldehyde. H3L
II 
is initially investigated for its 
metal binding ability using spectral analysis where it demonstrated a significant and selective 
~6.5-fold fluorescent enhancement for Zn
2+
. Upon complexation of H3L
II









and its lanthanide complexes were investigated for 
their DNA binding affinity and potential use as anticancer agents. H3L
II
 and its complexes 
demonstrate selectivity to cisplatin resistant A2780 carcinoma cells with EC50 values of 12.96 















respectively. Lanthanide complexes were found to increase toxicity of H3L
II
 towards 1321N1 




















Cancer-related diseases constitute to the top three of the world’s deaths and despite 
best efforts, there are still no cures.
1-3
 Chemotherapy is frequently the first treatment for 
cancer. Anticancer drugs typically function by either preventing or halting the division of 
rapidly dividing cells such as cancer cells often by interactions with DNA, preventing DNA 
replication resulting in apoptosis via the p53 pathway. However, other rapidly proliferating 
cells such as stem cells are also affected by such chemotherapies resulting in many adverse 
side effects towards the patient.
2,4,5
 Platinum-based complexes, such as cisplatin, have 
achieved great success as anticancer agents since their discovery in the 1960s.
6-8
 The success 
of platinum-based drugs is associated with their ability to bind to nucleobases and cleave 
DNA either hydrolytically or oxidatively. Binding to DNA results in a kink to formed in the 
DNA structure and transcription factors are blocked, hence, DNA replication and therefore 
cell division ceases.
5,9-12
 However, platinum-based drugs are associated with multiple side 
effects and often have succumbed to self-triggered drug resistance. Therefore, the 
development of alternative metal-based anticancer drugs is imperative for the enhancement of 
safer, more cancer-specific forms of chemotherapy.
8,13,14 
Lanthanides have been of great 
intrigue to chemists for their magnetic and phosphorescent properties. Their high 
coordination number and strong binding capabilities allow lanthanides to adopt many 
different coordinate geometries which remain intact even after excretion from the human 
body.
15,16
 Complexes of lanthanides have been widely investigated for their applications in 
medical imaging.
17,18
 Despite their vast medical usage, recent research suggests lanthanides 
exhibit cytoxicity.
16
 Due to the unique properties of lanthanides, lanthanide-based complexes 
may make ideal DNA binding and therefore anticancer agents. However, in part due to their 
labile nature, minimal research has explored the potential applications of lanthanide 
complexes towards cancer treatment.
18
 Lanthanide complexes may prove key to the 




is synthesised via the Schiff base condensation reaction between L-
ornithine and 2-hydroxy-1-naphthaldehyde. H3L
II 
was initially screened as a metal ion 
fluorescent sensor before being deemed unsuitable due to low effective concentration (EC) 






) complexes of H3L
II 
are then 
synthesised, characterised are then observed for their DNA binding potential by the use of 
spectral analysis. H3L
II 
and its lanthanide complexes are undergone further cell viability 
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assays via the MTT reduction method in the presence of 1321N1 astrocytoma, L6 myoblast 
cells and A2780 carcinoma cell lines to observe potential applications of H3L
II 
and its 
lanthanide complexes as anticancer drugs. The cell viability effects of coordinated 
lanthanides are then compared to that of H3L
II 
to make direct correlations between the effects 
of coordinated lanthanides and H3L
II
.     
 
3.3 Results and Discussion  
 





was synthesised from the condensation of L-ornithine and 2-hydroxy-1-
naphthaldehyde (1:2) at room temperature for 24 h in methanol upon the presence of a 
catalytic amount of glacial acetic acid (Fig. 3.1). It was then characterised via 
1
H NMR and 
13
CNMR, Electrospray Ionisation - High Resolution Mass Spectrometry (ESI-HRMS), FT-IR 
and simultaneous thermal analysis (STA).  
 
 








was initially characterised in a UV-visible (UV-vis) spectrophotometer 
indicating a peak maxima of 400 nm. H3L
II 
was then scanned in the presence of various metal 















fluorescent spectrum of H3L
II 
was obtained upon excitation at 399 nm indicating a broad, 
however, non-fluorescent peak at 464 nm. H3L
II
 was then scanned in the presence of various 
metal ions (2 eq.). A significant fluorescent enhancement response of ~6.5-fold is observed at 
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447 (blue) nm when H3L
II 
is in the presence of Zn
2+
 (2 eq.). A weak fluorescent enhancement 






 (2 eq.). Quenching of H3L
II
 








 (2 eq.). Results demonstrate that 
H3L
II 
has a significant and selectivity fluorescent response to Zn
2+





Figure 3.2 The fluorescence spectrum of H3L
II
 (20 µM) in the presence of various metal ions 
(2 eq.) in 20 mM HEPES solution at pH = 7.4. 
 
3.3.3 Competing Metal Ion 
 




 in the coexistence of other metal ions 
was conducted in order to determine the possibility of H3L
II
 to sense Zn
2+
 in the presence of 















 in the coexistence of Fe
3+
 
observed fluorescence quenching; however, still observed a detectable fluorescent 
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Figure 3.3 Fluorescence intensity of H3L
II
 (20 µM) with Zn
2+
 (2 eq.) under the coexistence 
of other metal cations (2 eq.) in 20 mM HEPES solution at pH = 7.4. The samples were 
excited at 399 nm and fluorescent intensities were taken at 447 nm.     
 
3.3.4 Cell Viability Assays 
 
Cell viability assays were performed with H3L
II
 and its lanthanide complexes (using 
the MTT method) upon 1321N1 astrocytoma, L6 myoblast and A2780 carcinoma cells as 
indicated in table 3.1. H3L
II 
itself is non-toxic towards 1321N1 astrocytoma cells, however, 
the lanthanide complexes drastically lowered half maximal effective concentration (EC50) 
values in comparison to H3L
II















complexes displayed some cytotoxicity towards L6 myoblast 





and its lanthanide complexes displayed selective cytotoxicity towards A2780 
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Cisplatin demonstrates EC50 
values >33 µM for the resistant A2780 carcinoma cell lines which is significantly more than 
that of H3L
II 
and its lanthanide complexes, which also display a substantial amount of 
specificity towards the cytotoxicity of A2780 carcinoma cell lines over neurological and 
muscle cell lines.
19
    
 
3.3.5 DNA Binding Assay - UV-vis Analysis 
 
As the primary pharmacological target of many metal-based anticancer drugs, DNA 
binding activities of H3L
II
 and its lanthanide complexes (25 µM) were obtained in a UV-vis 
spectrum in the absence and then in the presence of ctDNA (40 µM; Fig. 3.4). Results 
indicated mild amounts of absorbance shifting in all samples of H3L
II 
and its lanthanide 
complexes indicating DNA binding activity.  














 within 1321N1 astrocytoma, L6 myoblast 
and A2780 carcinoma cells (4 sig. fig; Λ = 595 nm; Error bars = STD; n = 6). The percentage change in EC 
value (∆; 3 sig fig.) in comparison to H3L
II 




Figure 3.4 Electronic spectra of a) H3L
II
 (black) and H3L
II 


























 upon addition of 
ctDNA (red) in Milli-Q water (250-500 nm). 
  
3.3.6 DNA Binding Assay - Fluorescent Analysis 
 
Ethidium bromide (EB) was used to allow for fluorescence of ctDNA forming 
ctDNA-EB (40 µM). Upon addition of H3L
II
 and its lanthanide complexes (25 µM), 
fluorescent enhancements, as well as blue fluorescent shifts, are observed in all molecules 
indicating the DNA binding of H3L
II 
and its lanthanide complexes (Fig. 3.5). Spectral DNA 
binding studies from both colourimetric and fluorescent analysis of H3L
II 
and its lanthanide 
complexes imply that all molecules are likely interacting with DNA within cells, resulting in 
apoptosis and thus low EC values. The DNA binding which is exhibited by H3L
II
 and its 




complexes. Many biomolecules, such as DNA, exhibited left-handed chirality, allowing for a 








Figure 3.5 The fluorescence spectrum of H3L
II
 and its lanthanide complexes interacting with 
ctDNA-EB in Milli-Q water (500-700 nm). 
 
3.4 Conclusion 
   
H3L
II 
and its lanthanide complexes were successfully synthesised and characterised. 
H3L
II 
displayed some potential as a Zn
2+
 sensor; however, its potential is limited due to its 




and its lanthanide 
complexes demonstrated selectively low EC values for A2780 carcinoma cells. This was 
significantly lower than that of cisplatin, evoking the potential use of H3L
II 
and lanthanide 
complexes as anticancer drugs. The lanthanide complexes exhibited drastically lower EC 
values in astrocytoma cells in respect to H3L
II
 indicating the selectivity of lanthanides to 
61 
enhance toxicity of ligands towards neurological cell lines. However, lanthanide complexes 
had little effect on cell viability of L6 myoblast and 1321N1 astrocytoma cell lines. DNA 
binding studies affirmed the potential mechanism of how H3L
II 
and its lanthanide complexes 
are evoking cytotoxic responses, by binding to DNA, preventing cell division, resulting in 
apoptosis. 
 
3.5 Experimental  
  
3.5.1 Chemicals and Reagents  
 
All chemicals, solvents and cell lines were purchased from commercial sources of 
commercial grade and used without further purification. All aqueous solutions were prepared 
































) or nitrate (Pb
2+
) salts of analytical grade, then standardised using literature 













NMR spectra were measured on a Bruker DRX-300 NMR spectrometer. FT-IR 
measurements were conducted on a Bruker Vertex 70 spectrometer. Electrospray ionisation 
high resolution mass spectra (ESI-HRMS) were collected using a Waters Xevo QToF 
quadrupole mass spectrometer with samples dissolved in methanol. Simultaneous thermal 
analysis (STA) was undertaken on a Netzsch STA449 C Jupiter thermo-microbalance. An 
Edinburgh instruments FS5 Spectrofluorometer was used to conduct all fluorescent 
measurements. Agilent Cary 100 spectrophotometer was used to conduct the UV-vis 
experiments. Quartz cuvettes with a 1 cm optical path length were used for all fluorescent and 
colourmetric experiments. Fluorescent and colourimetric measurements, as well as cell 
viability assays, were graphed using Origin Pro 9.0. Scanning electron microscopy–electron 
dispersive spectroscopy (SEM-EDS) analysis was conducted on a Phenom XL instrument. 




3.5.3 Synthesis of H3L
II 
 
L-ornithine (300 mg, 2.27 mmol) and 2-hydroxy-1-naphthaldehyde (782 mg, 4.54 
mmol) was dissolved in methanol (25 mL) into a conical flask. Five drops of glacial acetic 
acid were then added to the mixture. The mixture was stirred at room temperature (rt) for 24 
h. The precipitate was then collected using filtration and washed thoroughly in methanol and 
then diethyl ether. The precipitate was left to dry overnight resulting was a bright yellow 
powder with a yield of ~90%. m.p. 197.5 °C, 
1
HNMR: (300 MHz, DMSO-d6 with TMS) δ 
9.223 (s, 1H, N=CH), δ 9.120 (s, 1H, N=CH), δ 8.090-6.733 (m, ArH), δ 4.544 (t, J = 6.82 
Hz, 1H, CH), δ 3.722 (t, 2H, CH2) δ 2.079 (m, 1H, CH), δ 1.991 (m, 1H, CH), δ 1.772 (m, 
2H, CH2). 
13
CNMR: (75 MHz, DMSO-d6 with TMS) δ 176.95, δ 174.85, δ 172.06, δ 159.62, 
δ 159.11, δ 136.93, δ 136.9, δ 134.13, δ 133.79, δ 128.84, δ 128.75, δ 127.87, δ 127.73, δ 
125.57, δ 125.30, δ 124.26, δ 122.51, δ 122.04, δ 118.72, δ 118.38, δ 106.39, δ 105.61, δ 




.   FT-IR: 3027.02 
cm
-1
 (O-H, carboxylic acid), 2929.32 cm
-1
 (O-H, phenol), 1716.96 cm
-1
 (O=C, carboxylic 
acid), 1615.62 cm
-1
 (C=N).  UV−vis (1 cm optical path length, Milli-Q H2O, HEPES 20 mM, 
pH = 7.4): 20 μM H3L
II
, λmax = 414 nm (abs = 0.35585, ε = 17 793). 
 






Potassium hydroxide (46.6 mg, 0.681 mmol) was dissolved in 10 mL methanol. H3L
II
 
(100 mg, 0.227 mmol) was completely dissolved in the mixture and  filtered. The filtrate was 
then collected and stirred at rt for 5 min. Europium nitrate hexahydrate (50.6 mg, 0.114 
mmol) was dissolved in 10 mL methanol and added dropwise to the mixture. The mixture 
was then stirred for a further 2 h and filtered. The precipitate was then collected and dried 







2] +H2 + K2]]
+
 FT-IR: 3053.30 cm
-1
 (O-H, carboxylic acid), 2917.94 cm
-1
 
(O-H, phenol), 1615.80 cm
-1










Potassium hydroxide (46.6 mg, 0.681 mmol) was dissolved in 10 mL methanol. H3L
II
 
(100 mg, 0.227 mmol) was completely dissolved in the mixture and filtered. The filtrate was 
then collected and stirred at rt for 5 min. Gadolinium nitrate hexahydrate (51.5 mg, 0.114 
63 
mmol) was dissolved in 10 mL methanol and added dropwise to the mixture. The mixture 
was then stirred for a further 2 h and filtered. The precipitate was then collected and dried 







2] +H2 + K2]]
+
 FT-IR: 2989.03 cm
-1
 (O-H, carboxylic acid), 2900.90 cm
-1
 
(O-H, phenol), 1615.77 cm
-1










Potassium hydroxide (46.6 mg, 0.681 mmol) was dissolved in 10 mL methanol. H3L
II
 
(100 mg, 0.227 mmol) was completely dissolved in the mixture and filtered. The filtrate was 
then collected and stirred at rt for 5 min. Dysprosium nitrate hexahydrate (52.1 mg, 0.114 
mmol) was dissolved in 10 mL methanol and added dropwise to the mixture. The mixture 
was then stirred for a further 2 h and filtered. The precipitate was then collected and dried 







2] +H2 + K2]]
+
 FT-IR: 2989.06 cm
-1
 (O-H, carboxylic acid), 2900.95 cm
-1
 
(O-H, phenol), 1615.91 cm
-1




3.5.7 Fluorescent and UV−Vis Spectroscopy  
 
A stock solution of H3L
II
 (2 mM) was prepared in DMSO; this solution was used for 
all spectral experiments. Metal interaction experiments were carried out by aliquoting 
appropriate volumes of H3L
II
 stock solution to 20 µM and metal ions to 40 µM (2 eq.) in 5 
mM HEPES buffer at 7.4 pH in Milli-Q water to a total cuvette volume of 3 mL. All 
fluorescent studies were excited at 399 nm and scanned from 409-700 nm prepared ~12 h 
prior to running, where they were stored in a dark, dry environment at standard laboratory 
conditions. All fluorescent experiments were conducted at slits of ex/em = 4/4 nm.  
 
3.5.8 Cell Culturing 
 
Human 1321N1 cell line (1321N1 astrocytoma; purchased from Sigma-Aldrich/ 
ATCC) and immortalised rat skeletal myoblasts cell line (L6 myoblast; purchased from 
ATCC) were grown in Dulbecco's modified eagle medium (DMEM). A2780 human ovarian 
cancer cell line (A2780 carcinoma; purchased from ATCC) were grown in Rosewell Park 
Memorial Institute medium (RPMI-1640). All media of all cells lines used were 
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). All cells were cultured at 37 °C in a 95% air, 5% CO2 incubator. 
 
3.5.9 Cell Viability Assay 
 
Cells (either 1321N1 astrocytoma, L6 myoblast or A2780 cell lines) were seeded into 
a 96-well plate and filled with complete DMEM (for 1321N1 astrocytoma and L6 myoblast 
cells) or RPMI-1640 (for A2780 carcinoma cell line) to a total volume of 190 µL containing 







 (10 mM, 5 mM, 1.25 mM) were prepared in sterile Milli-Q water and DMSO (1:1, 
v/v) solutions. 10 µL of sextet concentration of 0, 20, 50, 100, 150, 200, 300, 350, 400 and 






 were prepared into the 96 well plates and incubated for 24 h. 
50 µL of 5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was 
added into each well and the cells were then left to incubate (37 °C, CO2 5%) for a further 2 
h. The media was decanted from each well and 100 µL of DMSO was added into each well to 
solubilise the formazan crystals. The 96 plate well was gently agitated before optical 
absorbance was measured at 595 nm using the BMG FLUOstar OPTIMA microplate reader. 
The values were then calculated as the mean ± standard deviation errors of six independent 
experiments. The cell viability was expressed as the optical absorbance of formazan at 595 
nm. EC values were determined using Origin Pro 9.0 sigmoidal logistics curves. 
  
3.5.10 ctDNA Sample Preparation 
 






(2 mM) were prepared in DMSO. A Stock 
solution of ctDNA (4 mM) was calculated using Beer’s law using the molar absorption 




 at 258 nm in sodium chloride (5 mM).
23
 The UV absorbance 
ratio (260 nm over 280 nm) was calculated to be greater than 1.8, indicating that the ctDNA 
was sufficiently free of protein.
24
 The DNA was then stored at 4 °C and used within 6 months 
of preparation.  
 
3.5.11 DNA Binding Assay - UV-vis Analysis 
 






were prepared in a cuvette of Milli-Q water and 
65 
measured from 200-800 nm. Additions of ctDNA (40 µM) were aliquoted into the cuvette 
and incubated for one minute. The samples were scanned again from 200-800 nm to observe 






with ctDNA.  
 
3.5.12 DNA Binding Assay - Fluorescent Analysis 
 
A stock solution of ethidium bromide (EB; 500 µM) was prepared in Milli-Q water. 
40 µM of EB was aliquoted to a cuvette of Milli-Q water and measured. ctDNA (40 µM) was 






 (25 µM) 
were then added to observe DNA binding interactions. All experiments were excited at 260 
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3.9 Supplementary Information 
 
Figure S3.1 The STA data of H3L
II
 (40-250 °C). 
 
Figure S3.2 The 
1
HNMR spectrum of H3L
II
 in DMSO-d6. 
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Figure S3.3 The 
13
CNMR spectrum of H3L
II
 in DMSO-d6. 
 






 in methanol from 50 – 800 m/z. Inset: On the 
left, the structure and molar mass of H3L
II
. On the right, the predicted (above) and 




.   
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2] +H2 + K2]]
+
 in methanol from 700 – 1500 






On the right, the 
predicted (above) and experimental (bellow) isotopic patterns of [EuL
II










2] +H2 + K2]]
+
 in methanol from 700 – 1500 






On the right, the 
predicted (above) and experimental (bellow) isotopic patterns of [GdL
II











2] +H2 + K2]]
+
 in methanol from 700 – 1500 






On the right, the 
predicted (above) and experimental (bellow) isotopic patterns of [[DyL
II




























Figure S3.12 EDS spectrum of H3L
II
. Inset: At the top, the elemental composition of H3L
II
 
and on the right, backscattered SEM micrograph of H3L
II 
at 500 x magnification. 
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 at 500 x 
magnification. 
 































 at 500 x 
magnification. 
 
Figure S3.16 Cell viability of 1321N1 astrocytoma cells treated with varying concentrations 














 for 24 h incubation 
periods, determined by an MTT reduction assay. Λ = 595 nm, Error bars = STD (n = 6). 
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Figure S3.17 Cell viability of L6 myoblast cells treated with varying concentrations (0–500 














 for 24 h incubation periods, 
determined by an MTT reduction assay. Λ = 595 nm, Error bars = STD (n = 6). 
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Figure S3.18 Cell viability of A2780 carcinoma cells treated with varying concentrations (0–














 for 24 h incubation 
periods, determined by an MTT reduction assay. Λ = 595 nm, Error bars = STD (n = 6). 
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 in the 
presence of various metal ions.  
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Chapter 4 – A Selective ‘Turn-on’ Fluorescent Sensor for Detecting Al
3+
 in 




4.1 Abstract  
 
 Despite its toxicity; organisms are exposed to aluminium by an array of household 
appliances, utensils, cosmetics and pharmaceuticals. Aluminium has some links to 
Alzheimer’s disease (AD); however, many of these claims are frequently disputed. At a low 
pH, aluminium is readily solubilised in water and is potentially toxic to wildlife either 
directly or due to biomagnification. Therefore, the need to study the effects of Al
3+
 is 
imperative to enhance the understanding of its potential roles in biology. Fluorescent sensors 
are in great demand for the study metal ions in bioinorganic chemistry. However, many of the 
current Al
3+ 
fluorescent sensors come with their limitations. Herein, we synthesise and 
characterise ligand (H3L
III
) via the Schiff base condensation reaction between L-cysteine and 
2-hydroxy-1-naphthaldehyde and analyse its potential as an Al
3+
 ‘turn-on’ fluorescent 




 with a 17-fold fluorescent 
enhancement which exhibits little effect in the coexistence of competitively binding metals. 
H3L
III 
demonstrates a 1:1 ligand-to-metal stoichiometry with a low limit of detection (LoD) 
of 3.46 nM. H3L
III 
observes no effect on cell viability and is able to detect Al
3+
 in 321N1 







Aluminium is the most abundant metal in the lithosphere, constituting to 8.3% of its 
total mass.
1
 Aluminium is also prevalent within humans and its overexposure has some links 
with the development of Alzheimer’s disease (AD).
2-5
 According to the Department of 
Agriculture and Food, Western Australian government, aluminium sensitive plants require 
only 2-5 ppm of Al
3+ 
to be toxic to the roots of such plants. Within acidic environments, 
aluminium is readily solubilised due to its oxidation into Aluminium oxide. Once soluble, 
aluminium is then potentially toxic to organisms within its adjacent environment. This is 
particularly problematic within industrialised areas, where chemical spills, as well as, the 
formation of acid rain result in lowering pH, allowing aluminium to dissolve, ruining 
agriculture and harming lifeforms.
6-8
  Recently, aluminium has acquired much interest from 
scientists within medical fields for its possible role in the development of AD.
9
 As many of 
these claims come with contrary counter-arguments, the demand for developing more 
advanced methods of sensing Al
3+
 is constantly on the rise. Much attention has therefore been 
focused on the development of Al
3+ 
fluorescent sensors for their biological applications.
10-12
 
Unfortunately, many of the current Al
3+
 sensors are marked with their limitations. Many that 
currently exist are limited by complicated synthetic pathways with low yields and are 
inappropriate for biological applications due to their toxicity or lack of testing in biological 
systems.
13,14
 Therefore, the development of new fluorescent sensors for Al
3+
 is imperative to 
enhance the understanding of Al
3+




) is synthesised via the Schiff base condensation reaction between L-
cysteine and 2-hydroxy-1-naphthaldehyde. L-cysteine is a water-soluble amino acid with 
high binding affinity to metal ions.
15-17
 2-hydroxy-1-naphthaldehyde is a prevalent 
fluorophore, commonly explored for its role in the design of fluorescent sensors.
18
 Schiff 
bases are wildly exploited for their unique properties. Due to a lone pair of electrons upon 
their imine functional group, photo-induced electron transfer (PET) is a prevalent method for 





4.3 Results and Discussion 
 





was synthesised from the condensation of L-cysteine and 2-hydroxy-1-
naphthaldehyde at room temperature for 24 h in methanol upon the presence of a catalytic 
amount of glacial acetic acid (Fig. 4.1). It was then characterised via 
1
H NMR and 
13
CNMR, 
Electrospray Ionisation - High Resolution Mass Spectrometry (ESI-HRMS), FT-IR and 













was examined by a UV-visible spectrophotometer (UV-vis) indicating a peak 
maxima of 414 nm. H3L
III 
was then scanned in the presence of various metal ions (2 eq.) 












. A fluorescent spectrum of 
H3L
III 
was obtained when excited at 395 nm indicating a broad, however, mostly non-
fluorescent peak of H3L
III
 at 456 nm. H3L
III
 was then scanned in the presence of various 
metal ions (2 eq.). A significant fluorescent enhancement response of ~17-fold is observed at 
437 nm (blue) when H3L
III 
is in the presence of Al
3+
 (2 eq.). A weak fluorescent enhancement 
is also exhibited at 455 nm when in the presence of Zn
2+




(2 eq.) at 456. Weak quenching of H3L
III
 occurs when in the presence 
of Fe
3+
 (2 eq.). Results demonstrate that H3L
III 
has a significant and selectivity fluorescent 
response to Al
3+




 was then measured as 
a function of time where fluorescence intensity plateaued at ~300 min (Fig. 4.2).  
 
 
Figure 4.2 The fluorescence spectrum of H3L
III
 (20 µM) in the presence of various metal 
ions (2 eq.) in 20 mM HEPES, 5 mM GSH water solution at pH = 7.4. Inset: A scatter plot of 
the fluorescence of H3L
III
 (20 µM) in the presence of 2 eq. Al
3+
 in 20 mM HEPES, 5 mM 
GSH, Milli-Q water solution at pH = 7.4, as a function of time (0-600 min).   
 












with other metal ions can be observed under the naked eye when excited with ultraviolet 
(UV) light at 365 nm (Fig. 4.3). As observed H3L
III
 in the presence of Al
3+
 emits light at a 




in the presence of other 
83 
metal ions. Mild fluorescent enhancement can also be observed when H3L
III 
is in the presence 
of Zn
2+
, however, this is barely detectable. This pronounced fluorescent enhancement of 
H3L
III 
at 437 nm when in the presence of Al
3+





PET phenomenon, may explain the mechanism of how H3L
III 
acts as a ‘turn-on’ fluorescent 
enhancer for Al
3+
. Electrons from the imine nitrogen atom of the Schiff base may invoke 
contributions to PET, which quench the fluorescence intensity of H3L
III
. However, when 
H3L
III 
chelates to the strongly bound, diamagnetic Al
3+
, the quenching is inhibited and the 








Figure 4.3 Detection of Al
3+
 by the naked eye using H3L
III
 (20 µM) and H3L
III
 in the 
presence of a series of metal cations (2 eq.) under UV light (365 nm) in 20 mM HEPES, 5 
mM GSH, Milli-Q water solution at pH = 7.4. 
 
4.3.4 Competing Metal Ion 
 




 in the coexistence of other metal ions 
was conducted in order to determine the capabilities of H3L
III
 to sense Al
3+
 in the presence of 
potentially interfering ions. All samples were excited at 395 nm and fluorescent intensities 































)  respectively, which are all clearly detectable. All other metal ions observed very 






Figure 4.4 Fluorescence intensity of H3L
III
 (20 µM) with Al
3+
 (2 eq.) under the coexistence 
of other metal cations (2 eq.) in 20 mM HEPES, 5 mM GSH, Milli-Q water solution at pH = 
7.4. The samples were excited at 395 nm and fluorescent intensities were taken at 437 nm.   
 
4.3.5 Limit of Detection (LoD) 
 




(20 µM) was conducted which determined the 
limit of detection (LoD) of H3L
III
 where all samples were excited at 395 nm and fluorescent 
intensities were taken at 437 nm. The titration determined a LoD of 3.46 nM and a limit of 
quantification (LoQ) of 15.5 nM. The metal titration also indicated a 1:1 ligand-to-metal 




Figure 4.5 Fluorescence titration of H3L
III
 upon addition of increasing amounts of Al
3+
 (0-2 
eq.) in methanol. Inset: Fitting of the fluorescence titration curve of H3L
III
 in methanol. LoD 
= 3.46 nM and LoQ = 15.5 nM determined by the following equations 3σ/m and 10σ/m 
respectively. 
 
4.3.6 Job’s plot 
 




in methanol to a total concentration 
of 50 µM. Fluorescent intensities were excited at 395 nm and taken at 437 nm. The Job’s plot 
intersect at a molar fraction of 0.50 matched data from MS and titration indicating a 1:1 









 at λmax = 437 nm. Intersect of linear plots at molar 
fraction of 0.50, indicating a 1:1 ligand-to-metal stoichiometry. 
 
4.4 Applications in Biological Systems 
 
4.4.1 Detection of Al
3+
 in Different Water Samples 
  
At a constant concentration of H3L
III
 (20 µM), water samples of tap and Hawkesbury 





strong fluorescent enhancement responses for Al
3+ 
in tap water as well as Hawkesbury river 
water, in particularly beyond 200 µM (Fig. 4.7). 




Figure 4.7 Fluorescent response of H3L
III
 (20 µM) in the presence of different concentrations 
(0-200 µM) of spiked Al
3+ 
in tap water (a.) and Hawkesbury river water (b.) as well as the 
fluorescence of the respective water samples with no treatment. The samples were excited at 
395 nm and fluorescent intensities were taken at 437 nm.   
 
4.4.2 Cell Viability Assay 
 
A cell viability assay of H3L
III
 was carried out using the MTT method at varying 
concentrations in 1321N1 astrocyte cells which implied the suitability of H3L
III 
for biological 
applications. Results indicated that up to 500 µM, H3L
III 
had no effect on cell viability 




 in biological systems. Minor 





Figure 4.8 Percentage (%) of cell viability of 1321N1 astrocyte cells treated with different 
concentrations (0–500 μM) of H3L
III
 for a 24 h incubation period, determined by an MTT 
reduction assay. Error bars = STD (n = 5). 
 
4.4.3 Cellular Imaging 
 
Confocal microscopy studies displayed the ability of H3L
III
 to detect Al
3+
 in 1321N1 
astrocyte cells (Fig. 4.9). Upon addition of H3L
III 
(40 µM), fluorescence enhancement occurs 




is inducing such 
response based upon preliminary in vitro experiments. Further, more advanced, 
experimentation may confirm that no other interaction is inducing a similar fluorescent 
response upon addition of H3L
III 





Figure 4.9 Confocal microscope images of 1321N1 astrocyte cells. a), b), c) indicate bright-
field, fluorescent and overlay images, respectively, of the cells upon in Phosphate buffered 
saline (PBS) buffer with no treatment. Images d), e) and f) indicate bright-field, fluorescent 
and overlay images, respectively, of the cells treated with H3L
III
 (40 µM) in PBS buffer. All 
experiments were conducted under 100 x magnification, excited with a 405 nm laser. Scale 
bars represent 50 µm. 
 




was synthesised, characterised and displays a significant, selective, fluorescent 
enhancement response to Al
3+
 at 437 nm. A stoichiometry of 1:1 ligand-to-metal ratio was 





tested in the coexistence of other metals and in different water samples indicating that H3L
III 
can sense for Al
3+
 in various environments. Cell viability assays indicate that H3L
III 
has no 
effect on cell viability and thus is suitable for cellular studies. H3L
III 
was thereby tested for its 
potential fluorescent sensing capabilities in cellular conditions, using a confocal microscope. 
Here, H3L
III 
indicated that it can sense intracellular Al
3+ 










NMR data. Purification, isolation and identification of the active 
compound is essential for future research. 
 
4.6 Experimental  
 
4.6.1 Chemicals and Reagents  
 
All chemicals, solvents and cell lines were purchased from commercial sources of 
commercial grade and used without further purification. All aqueous solutions were prepared 
































) or nitrate (Pb
2+
) salts of analytical grade, then standardised using literature 













NMR spectra were measured on a Bruker DRX-300 NMR spectrometer. FT-IR 
measurements were conducted on a Bruker Vertex 70 spectrometer. Electrospray ionisation 
high resolution mass spectra (ESI-HRMS) were collected using a Waters Xevo QToF 
quadrupole mass spectrometer with samples dissolved in methanol. Simultaneous thermal 
analysis (STA) was undertaken on a Netzsch STA449 C Jupiter thermo-microbalance. An 
Edinburgh instruments FS5 Spectrofluorometer was used to conduct all fluorescent 
measurements. Agilent Cary 100 spectrophotometer was used to conduct the UV-vis 
experiments. Quartz cuvettes with a 1 cm optical path length were used for all fluorescent and 
colourmetric experiments. Fluorescent and colourimetric measurements, as well as cell 
viability assays, were graphed using Origin Pro 9.0. Scanning electron microscopy–electron 
dispersive spectroscopy (SEM-EDS) analysis was conducted on a Phenom XL instrument. 




4.6.3 Synthesis of H3L
III 
 
L-cysteine (440 mg, 3.63 mmol) and 2-hydroxy-1-naphthaldehyde (625 mg, 2.66 
mmol) was dissolved in methanol (25 mL) into a conical flask. Five drops of glacial acetic 
acid then added to the mixture. The mixture was then stirred at room temperature (rt) for 24 
h. The precipitate was collected using gravity filtration and washed thoroughly in methanol 
and then diethyl ether. The precipitate was left to dry overnight resulting was an off-white 
powder with a yield of ~90%. m.p. 154.3 °C, 
1
HNMR: (300 MHz, DMSO-d6 with TMS) δ 
7.940-7.083 (m, ArH), δ 6.377 (s, 0.4H, N=CH), δ 4.030 (t, J = 8.22 Hz, 0.8H, SH), δ 3.466 
(t, J = 8.2 Hz, 1H, CH), δ 3.171 (m, 0.8H, CH2). 
13
CNMR: (75 MHz, DMSO-d6 with TMS) δ 
172.64, δ 154.72, δ 131.93, δ 131.69, δ 129.63, δ 129.63, δ 128.48, δ 127.75, δ 126.63, δ 





. FT-IR: 3675.80 cm
-1





 (S-H), 1635.07 cm
-1
 (O=C, carboxylic acid), 1519.20 cm
-1
 (C=N).  
UV−vis (1 cm optical path length, Milli-Q H2O, 5 mM glutathione (GSH), HEPES 20 mM, 
pH = 7.4): 20 μM H3L
III
, λmax = 414 nm (abs = 0.1457, ε = 7 285). 
 




Potassium hydroxide (44.4 mg, 0.791 mmol) was dissolved in 10 mL methanol. H3L
III
 
(100 mg, 0.302 mmol) was completely dissolved in the mixture and filtered. The filtrate was 
then collected and stirred at rt for 5 min. Aluminium chloride (40.3 mg, 0.604 mmol) was 
dissolved in 10 mL methanol and added dropwise to the mixture. The mixture was then 
stirred for a further 2 h and filtered. The precipitate was then collected and dried overnight. 







 FT-IR: 3675.79 cm
-1





 (S-H), 1620.07 cm
-1




4.6.5 Fluorescent and UV−Vis Spectroscopy  
 
A stock solution of H3L
III
 (2 mM) was prepared in DMSO; this solution was used for 
all spectroscopic experiments. Metal interaction experiments were carried out by aliquoting 
appropriate volumes of H3L
III
 stock solution to 20 µM and metal ions to 40 µM (2 eq.) in 
mimicked intracellular conditions of 20 mM glutathione (GSH), 5 mM HEPES buffer at 7.4 
92 
pH in Milli-Q water to a total cuvette volume of 3 mL.
25
 AlCl3 was added as 2 eq. (40 µM), 
with competing metal ions also as 2 eq. (40 µM). Job’s plot measurements were undertaken 




 and AlCl3 were prepared in various molar 
ratios, with the combined concentration of both at 50 μM to a total cuvette volume of 3 mL. 
These molar ratio mixtures were prepared in a methanol to reduce external interactions with 
H3L
III
 and AlCl3. All fluorescent studies were excited at 395 nm and scanned from 405-700 
nm. All fluorescent experiments were prepared ~ 12 h prior to running, where they were 
stored in a dark, dry environment at standard laboratory conditions. Mimicked intracellular 
solution studies were performed at slits of ex/em = 5/5 nm, whereas methanolic studies at 
ex/em = 2/2 nm.   
 










 a metal titration approach was used in 
methanol, where samples of H3L
III
 (20 µM) was prepared with a various equivalents of 
AlCl3. The samples were left to incubate in a dark, dry environment at standard laboratory 
conditions for ~ 12 h prior to run time. The limit of detection (LoD) and limit of 
quantification (LoQ) were calculated using 3σ/m and 10σ/m, respectively, where σ is the 
standard deviation of a blank solution and m is the slope of the linear plot obtained.
28
 For the 
standard deviation (σ) determination, we took 10 repeated spectra measurements of a blank 
solution (H3L
III
 solution in the same conditions used for measurements but without any 
addition of AlCl3) and calculated the standard deviation for the fluorescent values at 437 nm, 
obtaining a value of σ = 90.30311. 
 
4.6.7 Cell Culturing 
 
Human 1321N1 cell line (1321N1 astrocytoma; purchased from Sigma-Aldrich/ 
ATCC) were grown in Dulbecco's modified eagle medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and antibiotics (penicillin-100 µg ml
−1
; streptomycin-50 µg ml
−1
). 
Cells were cultured at 37 °C in a 95% air, 5% CO2 incubator. 
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4.6.8 Cell Viability Assay 
 
1321N1 astrocytoma cells were seeded into a 96-well plate and filled with complete 
DMEM to a total volume of 195 µL containing 10,000 cells each and then incubated (37 °C, 
CO2 5%) for 24 h. Stock solutions of H3L
III
 (20 mM, 10 mM, 2.5 mM) were prepared in 
sterile DMSO. 5 µL of pentet concentration of 0, 20, 50, 100, 150, 200, 300, 350, 400 and 
500 µM of H3L
III
 were prepared into the 96 well plates and incubated for 24 h. 50 µL of 5 
mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added into 
each well and the cells were then left to incubate (37 °C, CO2 5%) for a further 2 h. The 
media was decanted from each well and 100 µL of DMSO was added into each well to 
solubilise the formazan crystals. The 96 plate well was gently agitated before optical 
absorbance was measured at 595 nm using the BMG FLUOstar OPTIMA microplate reader. 
The values were then calculated as the mean ± standard deviation errors of six independent 
experiments. The cell viability was expressed as the optical density ratio of the treatment 
compared to control samples.   
 
4.6.9 Detection of Al
3+
 in Different Water Samples 
  
Tap water sample was taken from Parramatta Council, Sydney, NSW, Australia. 
Hawkesbury River water samples were collected from still river water samples from Bobbin 
Head, Hornsby Shire Council, Sydney, NSW, Australia. Blank water samples were initially 
measured as controls. H3L
III 
(20 µM) was added into varying spiked samples of AlCl3 (0, 10, 
20, 50, 100 and 200 µM) to a total volume of 3 mL in each of the water samples. All water 
samples were excited at 395 nm and data was collected at 437 nm with slit sizes of ex/em = 
5/5 nm.    
 
4.6.10 Cell Imaging 
 
1321N1 astrocytoma cells were viewed under the Inverted Leica TCS SP5 laser 
scanning confocal microscope at the confocal bio-imaging facility WSU, with all parameters 
according to table 4.1. A fluorodish of 1321N1 cells was prepared and incubated (37 °C, CO2 
5%) 24 h prior to experimentation. The cells were then viewed with no added treatment in 
PBS buffer. H3L
III
 (40 µM; in DMSO) was then added to the fluorodish and incubated for 10 
94 
min where it was then washed three times with PBS. All images captured were processed 
using LAS AF software.          
 
Table 4.1 Parameters used for all cell imaging studies of 1321N1 astrocytoma. 




X 1024 98.41 µm 0.00 µm 
Y 1024 98.41 µm 0.00 µm 
    
LUT Name Objective Aperture em Bandwidth 
Laser 405 
Diode, UV 
HC DL APO 
C52 63.0x1.20 
WATER UV 
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4.10 Supplementary Information 
 
Figure S4.1 The STA data of H3L
III
 (40-250 °C). 
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Figure S4.2 The 
1
HNMR spectrum of H3L
III
 in DMSO-d6. 
 
Figure S4.3 The 
13
CNMR spectrum of H3L
III
 in DMSO-d6 
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 in methanol from 50 – 800 m/z. Inset: On the 
left, the structure and molar mass of H3L
III
. On the right, the predicted (above) and 












 in methanol from 50 – 800 m/z. 
Inset: On the left, the predicted structure and molar mass of [AlL
III
H3COH]. On the right, the 
















Figure S4.8 EDS spectrum of H3L
III
. Inset: At the top, the elemental composition of H3L
III
 
and on the right, backscattered SEM micrograph of H3L
III 
at 500 x magnification. 
 
Figure S4.9 EDS spectrum of [AlL
III









at 500 x magnification. 
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the presence of various metal ions. 
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 Within this thesis report, three amino acid-derived Schiff base ligands were designed 




CNMR, FT-IR, HR MS-ESI, SEM-EDS, STA, P-XRD and SC-XRD upon the ligands and 
their respective metal complexes. Spectral analysis was conducted using a UV-vis and 
fluorescent spectrofluorometer to evaluate the metal binding affinity and examine the 
potential role of the three Schiff bases as chemosensors for metal ions. Cell viability assays 
determined the biocompatibility of the molecules. Fluorescent microscopy, as well as water 
sample studies, were conducted upon the Schiff bases that exhibited no effects on cell 
viability. This demonstrated the ability of the Schiff bases to selectively detect their desired 
metal analyte within biological and aqueous environments. Molecules deemed cytotoxic were 






) and analysed using spectral DNA binding 
studies, as well as cell viability assays, on myoblast, astrocytoma and carcinoma cell lines. 
Two fluorescent Al
3+
 sensors and four anticancer agents resulted from these studies as well as 
an enhanced knowledge of the roles of lanthanide complexes as potential anticancer agents. 
 
 In regards to chapter 1, an introduction was given which orchestrated the general 
concepts of supramolecular, bioinorganic, and fluorescent chemistry. Guidelines for 
designing ideal fluorescent sensors were evaluated and the general aims and scope of the 
thesis report were projected. 
 




 was successfully 
designed and synthesised from the Schiff base condensation reaction between L-tryptophan 
and 4-diethylamino salicylaldehyde. Spectral analysis explored the metal binding properties 
of H2L
I 
with an array of metal ion. The results indicated a blue-shift; 24-fold fluorescent 
enhancement of H2L
I
, selective for Al
3+
. Its binding affinity for Al
3+
 was strong enough to 
evoke a detectable fluorescent response, in the presence of other competing metal ions. 
Limited detection analysis determined a LoD of 61.5 nM and the ligand-to-metal 
stoichiometry was determined as 1:2, which supported the data indicated by a Job’s plot and 
MS. Cell viability assays determined that H2L
I 




able to detect Al
3+
 within AD relevant, 1321N1 astrocytoma cells. H2L
I 
was compared to a 
vast array of recent Al
3+
 fluorescent sensors, presenting its superiority, in particularly, for 
biological studies. H2L
I 
is therefore appropriate to be used as a fluorescence sensor in 
different aqueous and cellular environments.  
 
 Within chapter 3, the Schiff base ligand (H3L
II
) was successfully designed, 
synthesised and characterised. H3L
II 
displayed some potential as a selective Zn
2+
 fluorescent 
chemosensory, however, was toxic towards specific cell lines. H3L
II 
was therefore 













characterised. In 1321N1 astrocytoma cells, the lanthanide complexes exhibited lower EC50 












respectively, in regards to 
H3L
II
. Coordinated lanthanides had little effect upon the cell viability of H3L
II
 within L6 
myoblast cells. In A2780 carcinoma cells, H3L
II
 and its lanthanide complexes displayed EC50 















 respectively. This was significantly less than cisplatin and so DNA binding studies 
were conducted using spectral methods to determine the possible mechanism of H3L
II 
and its 
complexes for inducing low EC values. H3L
II 
and its lanthanide complexes were, therefore, 
determined to be potentially used as anticancer agents specific to ovarian carcinomas. 
Additionally, upon complexation, lanthanides enhanced cell toxicity specifically towards 
neuronal cells.  
 
 Lastly, in chapter 4, an Al
3+
 fluorescent sensor (H3L
III
) was synthesised and 





a 17-fold fluorescent enhancement response, which was not significantly deterred in the 
coexistence of other metal ions. The LoD of H3L
III 
was determined to be an exceptionally low 
3.46 nM and the ligand-to-metal stoichiometry was determined as 1:1. H3L
III 
displayed no 









was determined to be an 
appropriate Al
3+
 sensor; however, its synthesis yielded two products.  
 
5.2 Future Research  
 
 To expand upon chapter 2, the development of fluorescent sensors that are selective to 
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 and even anions such as CN
-
 
(most of which are intriguing due to their effects upon neurodegeneration) can be designed.
1-4
 
The development of sensors with fluorophores such as coumarin, fluorescein and 
naphthalimide, can be designed as these fluorophores exhibit ratiometric responses inducted 
by FRET and emit at low energy wavelengths.
5-7
 Both characteristics are ideal for fluorescent 
imaging in cellular environments. Quantum yield experiments may also assist with 
determining the effectivity of such ion chemosensors.      
 
To develop chapter 3 to a publishable state, H3L
II 
can be coordinated to form platinum 
and ruthenium complexes and observed for the effects on cell viability comparatively to that 
of the lanthanide complexes. These molecules may then undergo further characterisation 
using circular dichroism (CD) and gel electrophoresis, to enhance the understanding of the 
mechanism in which these potential anticancer drugs function. 
 
In chapter 4, further isolation (using chromatography) and characterisation of the 
active molecule is required to evaluate the possible real-world use of H3L
III
 as an Al
3+
 
fluorescent sensor. Once isolated, the active molecule will be re-examined for its metal 
binding and fluorescent characteristics to potentially be applied as a fluorescent sensor in 
aqueous and biological environments.  
106 
5.3 Reference List 
 
1. F. Zahir, S. J. Rizwi, S. K. Haq & R. H. Khan. Low dose mercury toxicity and human 
health. Environmental Toxicology and Pharmacology 20, 351–360 (2005). 
2. W.-J. Huang, X. Zhang & W.-W. Chen. Role of oxidative stress in Alzheimer’s disease 
(Review). Biomed. Rep. 4, 519–522 (2016). 
3. A. S. Prasad. Biochemistry of Zinc. (Springer Science & Business Media, 2013). 
4. M. P. Cuajungco & G. J. Lees. Zinc Metabolism in the Brain: Relevance to Human 
Neurodegenerative Disorders. Neurobiol. Dis. 4, 137–169 (1997). 
5. R. Parkesh, T. C. Lee & T. Gunnlaugsson. Highly selective 4-amino-1,8-naphthalimide 
based fluorescent photoinduced electron transfer (PET) chemosensors for Zn(II) under 
physiological pH conditions. Org. Biomol. Chem. 5, 310–317 (2007). 
6. X. Zhou et al. An FRET-based ratiometric chemosensor for in vitro cellular fluorescence 
analyses of pH. Biomaterials 33, 171–180 (2012). 
7. J.-S. Wu et al. Fluorescence Turn On of Coumarin Derivatives by Metal Cations:  A New 
Signaling Mechanism Based on C=N Isomerization. Org. Lett. 9, 33–36 (2007).  
 
